Publications
Selected publications
- Harmonizing Quality Improvement Metrics Across Global Trial Networks to Advance Paediatric Clinical Trials Delivery. (Journal article - 2024)
- European expert recommendations on clinical investigation and evaluation of high-risk medical devices for children. (Journal article - 2023)
- Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia. (Journal article - 2023)
- Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children (Journal article - 2023)
- Assessment of compatibility of rhIGF-1/rhIGFBP-3 with neonatal intravenous medications (Journal article - 2023)
- Research Networks and Accelerated Research Pathways for Perinatal Health (Chapter - 2023)
- Development and evaluation of an assessment of the age-appropriateness/inappropriateness of formulations used in children (Journal article - 2022)
- Health Equity in Pediatric Drug Development: Translating Aspiration into Operation (Journal article - 2022)
- Recommendations by the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) Working Group on preparedness of clinical trials about paediatric medicines process. (Journal article - 2021)
- The conect4children (c4c) Consortium: Potential for Improving European Clinical Research into Medicines for Children (Journal article - 2021)
2024
Balancing key stakeholder priorities and ethical principles to design a trial comparing intervention or expectant management for early-onset selective fetal growth restriction in monochorionic twin pregnancy: FERN qualitative study.
Mitchell, T. K., Popa, M., Ashcroft, R. E., Prasad, S., Sharp, A., Carnforth, C., . . . Woolfall, K. (2024). Balancing key stakeholder priorities and ethical principles to design a trial comparing intervention or expectant management for early-onset selective fetal growth restriction in monochorionic twin pregnancy: FERN qualitative study.. BMJ open, 14(8), e080488. doi:10.1136/bmjopen-2023-080488
Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial.
Lowe, J., Gillespie, D., Aboklaish, A., Lau, T. M. M., Consoli, C., Babu, M., . . . Kotecha, S. (2024). Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial.. The Lancet. Respiratory medicine, 12(8), 608-618. doi:10.1016/s2213-2600(24)00079-1
Challenges of modulating the risk of bronchopulmonary dysplasia in clinical trials - Authors' reply.
Lowe, J., Berrington, J., Gillespie, D., Turner, M., & Kotecha, S. (2024). Challenges of modulating the risk of bronchopulmonary dysplasia in clinical trials - Authors' reply.. The Lancet. Respiratory medicine, 12(8), e44. doi:10.1016/s2213-2600(24)00173-5
Correction: Neonatal sepsis definitions from randomised clinical trials.
Hayes, R., Hartnett, J., Semova, G., Murray, C., Murphy, K., Carroll, L., . . . Infection, Inflammation, Immunology and Immunisation (I4) section of the European Society for Paediatric Research (ESPR). (2024). Correction: Neonatal sepsis definitions from randomised clinical trials.. Pediatric research. doi:10.1038/s41390-024-03416-9
Diagnosis and management of selective fetal growth restriction in monochorionic twin pregnancies: A cross-sectional international survey.
Prasad, S., Khalil, A., Kirkham, J. J., Sharp, A., Woolfall, K., Mitchell, T. K., . . . FERN Study Team. (2024). Diagnosis and management of selective fetal growth restriction in monochorionic twin pregnancies: A cross-sectional international survey.. BJOG : an international journal of obstetrics and gynaecology. doi:10.1111/1471-0528.17891
Neurodevelopmental outcomes at 2 years in children who received sildenafil therapy in utero: The STRIDER randomised controlled trial.
Sharp, A., Cornforth, C., Jackson, R., Harrold, J., Turner, M. A., Kenny, L. C., . . . STRIDER group. (2024). Neurodevelopmental outcomes at 2 years in children who received sildenafil therapy in utero: The STRIDER randomised controlled trial.. BJOG : an international journal of obstetrics and gynaecology. doi:10.1111/1471-0528.17888
Harmonizing Quality Improvement Metrics Across Global Trial Networks to Advance Paediatric Clinical Trials Delivery.
Attar, S., Price, A., Hovinga, C., Stewart, B., Lacaze-Masmonteil, T., Bonifazi, F., . . . Fernandes, R. M. (2024). Harmonizing Quality Improvement Metrics Across Global Trial Networks to Advance Paediatric Clinical Trials Delivery.. Therapeutic innovation & regulatory science. doi:10.1007/s43441-024-00663-0
Is noxious stimulus-evoked electroencephalography response a reliable, valid, and interpretable outcome measure to assess analgesic efficacy in neonates? A systematic review and individual participant data (IPD) meta-analysis protocol
Perinatal Science International: A new meeting of the European Association of Perinatal Medicine.
Modi, N., Jacobsson, B., de Campos, D. A., & Perinatal Science International Writing Group. (2024). Perinatal Science International: A new meeting of the European Association of Perinatal Medicine.. European journal of obstetrics, gynecology, and reproductive biology, 297, 159-160. doi:10.1016/j.ejogrb.2024.04.018
2-year Neurodevelopmental outcomes in children who received Sildenafil Therapy in utero: The STRIDER RCT
Sharp, A., Cornforth, C., Jackson, R., Kenny, L., Alfirevic, Z., von dadelszen, P., . . . Harrold, J. (n.d.). 2-year Neurodevelopmental outcomes in children who received Sildenafil Therapy in utero: The STRIDER RCT. BJOG: an International Journal of Obstetrics and Gynaecology.
Oral misoprostol alone, compared with oral misoprostol followed by oxytocin, in women induced for hypertension of pregnancy: A multicentre randomised trial.
Mundle, S., Lightly, K., Durocher, J., Bracken, H., Tadas, M., Parvekar, S., . . . Weeks, A. D. (2024). Oral misoprostol alone, compared with oral misoprostol followed by oxytocin, in women induced for hypertension of pregnancy: A multicentre randomised trial.. BJOG : an international journal of obstetrics and gynaecology. doi:10.1111/1471-0528.17839
FEATURES OF THE PROGRESSION OF THE INFLAMMATORY RESPONSE IN NEWBORNS WITH NEONATAL ENCEPHALOPATHY
Popov, S., Profatylo, A., Turner, M., Smiian, O., & Vasylieva, O. (2024). FEATURES OF THE PROGRESSION OF THE INFLAMMATORY RESPONSE IN NEWBORNS WITH NEONATAL ENCEPHALOPATHY. Eastern Ukrainian Medical Journal, 12(1), 50-60. doi:10.21272/eumj.2024;12(1):50-60
Publication Recommendations to Report Laboratory Data of Neonates - a Modified Delphi Approach.
Vander Elst, Z., Hildebrand, H., Short, M. A., Henscheid, N., Ward, R., Ariagno, R., . . . International Neonatal Consortium. (2024). Publication Recommendations to Report Laboratory Data of Neonates - a Modified Delphi Approach.. Pediatric research. doi:10.1038/s41390-024-03094-7
How are socioeconomic inequalities in preterm birth explained by maternal smoking and maternal body mass index: A mediation analysis
McHale, P., Schlüter, D. K., Turner, M., Care, A., Barr, B., Paranjothy, S., & Taylor‐Robinson, D. (n.d.). How are socioeconomic inequalities in preterm birth explained by maternal smoking and maternal body mass index: A mediation analysis. Paediatric and Perinatal Epidemiology. doi:10.1111/ppe.13045
Harmonizing quality improvement metrics across global trial networks to advance paediatric clinical trials delivery
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group. (2024). Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.. The Lancet. Child & adolescent health, S2352-4642(23)00316-4. doi:10.1016/s2352-4642(23)00316-4
The neonatal adverse event severity scale: current status, a stakeholders' assessment, and future perspectives.
Allegaert, K., Salaets, T., Wade, K., Short, M. A., Ward, R., Singh, K., . . . Lewis, T. (2024). The neonatal adverse event severity scale: current status, a stakeholders' assessment, and future perspectives.. Frontiers in pediatrics, 11, 1340607. doi:10.3389/fped.2023.1340607
Exploring NICU nurses' views of a novel genetic point-of-care test identifying neonates at risk of antibiotic-induced ototoxicity: A qualitative study.
Brown, G., Warrington, N., Ulph, F., Booth, N., Harvey, K., James, R., . . . Macleod, R. (2024). Exploring NICU nurses' views of a novel genetic point-of-care test identifying neonates at risk of antibiotic-induced ototoxicity: A qualitative study.. Journal of advanced nursing. doi:10.1111/jan.16045
Stakeholders' perspectives on clinical trial acceptability and approach to consent within a limited timeframe: a mixed methods study.
Deja, E., Donohue, C., Semple, M. G., Woolfall, K., & BESS Investigators. (2024). Stakeholders' perspectives on clinical trial acceptability and approach to consent within a limited timeframe: a mixed methods study.. BMJ open, 14(1), e077023. doi:10.1136/bmjopen-2023-077023
The development of the Belgian paediatric clinical trial network.
Degraeuwe, E., Persijn, L., Nuytinck, L., Allegaert, K., De Taeye, L., Gasthuys, E., . . . Vande Walle, J. (2024). The development of the Belgian paediatric clinical trial network.. Acta clinica Belgica, 79(1), 34-45. doi:10.1080/17843286.2023.2283664
Chapter 1 Preface Overview of pediatric drug development and pharmacovigilance
Turner, M. A., Gasthuys, E., Dossche, L., & Allegaert, K. (2024). Chapter 1 Preface Overview of pediatric drug development and pharmacovigilance. In Essentials of Translational Pediatric Drug Development (pp. 3-19). Elsevier. doi:10.1016/b978-0-323-88459-4.00001-8
Performing clinical drug trials in acute and critically ill neonates and children
De Cock, P. A., Smits, A., Oualha, M., Stitt, G., Metsvaht, T., Smeets, N., . . . De Wildt, S. N. (2024). Performing clinical drug trials in acute and critically ill neonates and children. In Essentials of Translational Pediatric Drug Development (pp. 451-482). Elsevier. doi:10.1016/b978-0-323-88459-4.00018-3
Preface
Turner, M. A., Gasthuys, E., Dossche, L., & Allegaert, K. (2024). Preface. In Essentials of Translational Pediatric Drug Development (pp. 3-19). Elsevier. doi:10.1016/b978-0-323-88459-4.00001-8
Preterm prelabour rupture of membranes before 23 weeks' gestation: prospective observational study.
Goodfellow, L., Care, A., Curran, C., Roberts, D., Turner, M. A., Knight, M., & Zarko, A. (2024). Preterm prelabour rupture of membranes before 23 weeks' gestation: prospective observational study.. BMJ medicine, 3(1), e000729. doi:10.1136/bmjmed-2023-000729
The future of pediatric drug research: Science, context, and collaboration
Allegaert, K., Dossche, L., Gasthuys, E., & Turner, M. A. (2024). The future of pediatric drug research: Science, context, and collaboration. In Essentials of Translational Pediatric Drug Development (pp. 685-692). Elsevier. doi:10.1016/b978-0-323-88459-4.00026-2
The needs from the regulatory authorities' perspective—current status and worldwide initiatives
Klein, A. V., Turner, M. A., & Sato, J. (2024). The needs from the regulatory authorities' perspective—current status and worldwide initiatives. In Essentials of Translational Pediatric Drug Development (pp. 61-80). Elsevier. doi:10.1016/b978-0-323-88459-4.00004-3
Worldwide network initiatives in improving pediatric drug research
Attar, S., Degraeuwe, E., Walle, J. V., & Turner, M. A. (2024). Worldwide network initiatives in improving pediatric drug research. In Essentials of Translational Pediatric Drug Development (pp. 593-627). Elsevier. doi:10.1016/b978-0-323-88459-4.00023-7
2023
Development and performance of the c4c national clinical trial networks for optimizing pediatric trial facilitation.
Degraeuwe, E., van der Geest, T., Persijn, L., Nuytinck, L., Raes, A., Turner, M., . . . IMI2 project conect4children (c4c) consortium, including National Hubs/Networks Belgian Pediatric Clinical Research Network (BPCRN) (Belgium) and Pedmed-NL (Netherlands). (2023). Development and performance of the c4c national clinical trial networks for optimizing pediatric trial facilitation.. Frontiers in pediatrics, 11, 1302272. doi:10.3389/fped.2023.1302272
European expert recommendations on clinical investigation and evaluation of high-risk medical devices for children.
Guerlich, K., Patro-Golab, B., Barnacle, A., Baumann, U., Eicken, A., Fraser, A. G., . . . European Academy of Paediatrics. (2023). European expert recommendations on clinical investigation and evaluation of high-risk medical devices for children.. Acta paediatrica (Oslo, Norway : 1992), 112(11), 2440-2448. doi:10.1111/apa.16919
Prospective assessment of inter-rater reliability of a neonatal adverse event severity scale.
Salaets, T., Lacaze-Masmonteil, T., Hokuto, I., Gauldin, C., Taha, A., Smits, A., . . . Lewis, T. (2023). Prospective assessment of inter-rater reliability of a neonatal adverse event severity scale.. Frontiers in pharmacology, 14, 1237982. doi:10.3389/fphar.2023.1237982
The Neonatal and Paediatric Pharmacokinetics of Antimicrobials study (NAPPA): investigating amoxicillin, benzylpenicillin, flucloxacillin and piperacillin pharmacokinetics from birth to adolescence
Barker, C. I. S., Kipper, K., Lonsdale, D. O., Wright, K., Thompson, G., Kim, M., . . . NAPPA, S. C. (2023). The Neonatal and Paediatric Pharmacokinetics of Antimicrobials study (NAPPA): investigating amoxicillin, benzylpenicillin, flucloxacillin and piperacillin pharmacokinetics from birth to adolescence. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 78(9), 2148-2161. doi:10.1093/jac/dkad196
Association between maternal breastmilk microbiota composition and rotavirus vaccine response in African, Asian, and European infants: a prospective cohort study
Mandolo, J., Parker, E. P. K., Bronowski, C., Sindhu, K. N. C., Darby, A. C., Cunliffe, N. A., . . . Verghese, V. P. (n.d.). Association between maternal breastmilk microbiota composition and rotavirus vaccine response in African, Asian, and European infants: a prospective cohort study. The Journal of Infectious Diseases. doi:10.1093/infdis/jiad234
Use of Developmental Midazolam and 1-Hydroxymidazolam Data with Pediatric Physiologically Based Modeling to Assess Cytochrome P450 3A4 and Uridine Diphosphate Glucuronosyl Transferase 2B4 Ontogeny In Vivo.
Johnson, T. N., Howgate, E. M., de Wildt, S. N., Turner, M. A., & Rowland Yeo, K. (2023). Use of Developmental Midazolam and 1-Hydroxymidazolam Data with Pediatric Physiologically Based Modeling to Assess Cytochrome P450 3A4 and Uridine Diphosphate Glucuronosyl Transferase 2B4 Ontogeny In Vivo.. Drug metabolism and disposition: the biological fate of chemicals, 51(8), 1035-1045. doi:10.1124/dmd.123.001270
CLINICAL, METHODOLOGICAL AND PATIENT/PARENTEXPERT ADVICE IN PAEDIATRIC DRUG DEVELOPMENTVIA CONECT4CHILDREN
Mahler, F., Cheng, K., Lutsar, I., Escalera, B. N., Turner, M., & de Wildt, S. (2023). CLINICAL, METHODOLOGICAL AND PATIENT/PARENTEXPERT ADVICE IN PAEDIATRIC DRUG DEVELOPMENTVIA CONECT4CHILDREN. In ARCHIVES OF DISEASE IN CHILDHOOD Vol. 108 (pp. A4). doi:10.1136/archdischild-2023-ESDPPP.11
COLLABORATION IN NEONATAL AND PAEDIATRIC CLINICAL PHARMACOLOGY: CREATING A PEER-BASED MENTORING PLATFORM IN A PAN-EUROPEAN CLINICAL TRIAL NETWORK
Degraeuwe, E., van der Geest, T., Persijn, L., Montero Campos, E., Turner, M., & Vande Walle, J. (2023). COLLABORATION IN NEONATAL AND PAEDIATRIC CLINICAL PHARMACOLOGY: CREATING A PEER-BASED MENTORING PLATFORM IN A PAN-EUROPEAN CLINICAL TRIAL NETWORK. In ARCHIVES OF DISEASE IN CHILDHOOD Vol. 108 (pp. A4). doi:10.1136/archdischild-2023-ESDPPP.12
PAEDIATRIC CLINICAL TRIAL NEEDS AND REQUIREMENTS WITHIN BELGIUM
Degraeuwe, E., Persijn, L., Nuytinck, L., Raes, A., Turner, M., & Vande Walle, J. (2023). PAEDIATRIC CLINICAL TRIAL NEEDS AND REQUIREMENTS WITHIN BELGIUM. In ARCHIVES OF DISEASE IN CHILDHOOD Vol. 108 (pp. A3). doi:10.1136/archdischild-2023-ESDPPP.10
THE FLOOD OF STUDY FEASIBILITIES AND THE VALUE OF A CENTRALISED APPROACH
Degraeuwe, E., Persijn, L., Nuytinck, L., Raes, A., Turner, M., & Walle, J. V. (2023). THE FLOOD OF STUDY FEASIBILITIES AND THE VALUE OF A CENTRALISED APPROACH. In ARCHIVES OF DISEASE IN CHILDHOOD Vol. 108 (pp. A3). doi:10.1136/archdischild-2023-ESDPPP.9
Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia.
Terzić, V., Levoyer, L., Figarella, M., Bigagli, E., Mercier, N., De Gastines, L., . . . c4c safety group. (2023). Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia.. British journal of clinical pharmacology, 89(4), 1318-1328. doi:10.1111/bcp.15669
Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children
Cheng, K., Mahler, F., Lutsar, I., Escalera, B. N., Breitenstein, S., Vassal, G., . . . de Wildt, S. N. N. (2023). Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 16(3), 478-488. doi:10.1111/cts.13459
Standardizing Paediatric Clinical Data: The Development of the conect4children (c4c) Cross Cutting Paediatric Data Dictionary
Sen, A., Hedley, V., Owen, J., Cornet, R., Kalra, D., Engel, C., . . . Straub, V. (n.d.). Standardizing Paediatric Clinical Data: The Development of the conect4children (c4c) Cross Cutting Paediatric Data Dictionary. Journal of the Society for Clinical Data Management, 2(3). doi:10.47912/jscdm.218
Assessment of compatibility of rhIGF-1/rhIGFBP-3 with neonatal intravenous medications
Salamat-Miller, N., Turner, M. A., Bandekar, A., Dixit, N., Jochim, E., Mangum, B., . . . Barton, N. (2023). Assessment of compatibility of rhIGF-1/rhIGFBP-3 with neonatal intravenous medications. WORLD JOURNAL OF PEDIATRICS, 19(1), 58-67. doi:10.1007/s12519-022-00610-9
ETHANOL AS AN EXCIPIENT IN DRUG FORMULATIONS ADMINISTERED TO NEONATES: PHYSIOLOGICALLY--BASED PHARMACOKINETIC MODELING TO INFORM SAFETY
Freriksen, J., de Hoop-Sommen, M., Mulla, H., Turner, M., Pang, R., Robertson, N., . . . de Wildt, S. (2023). ETHANOL AS AN EXCIPIENT IN DRUG FORMULATIONS ADMINISTERED TO NEONATES: PHYSIOLOGICALLY--BASED PHARMACOKINETIC MODELING TO INFORM SAFETY. In CLINICAL PHARMACOLOGY & THERAPEUTICS Vol. 113 (pp. S86-S87). Retrieved from https://www.webofscience.com/
Research Networks and Accelerated Research Pathways for Perinatal Health
Turner, M. A. (2023). Research Networks and Accelerated Research Pathways for Perinatal Health. In COVID-19 and Perinatology (pp. 187-205). Springer International Publishing. doi:10.1007/978-3-031-29136-4_14
2022
The publication quality of laboratory values in clinical studies in neonates
Allegaert, K., Hildebrand, H., Singh, K., & Turner, M. A. A. (2022). The publication quality of laboratory values in clinical studies in neonates. PEDIATRIC RESEARCH. doi:10.1038/s41390-022-02385-1
A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome: two-year outcomes
Sweet, D. G., Turner, M., Stranak, Z., Plavka, R., Clarke, P., Stenson, B., . . . Speer, C. P. (2022). A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome: two-year outcomes. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 35(24), 4739-4742. doi:10.1080/14767058.2020.1863363
Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper
Smits, A., Annaert, P., Cavallaro, G., De Cock, P. A. J. G., de Wildt, S. N., Kindblom, J. M., . . . Allegaert, K. (2022). Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 88(12), 4965-4984. doi:10.1111/bcp.14958
Development and evaluation of an assessment of the age-appropriateness/inappropriateness of formulations used in children
Duncan, J. C., Bracken, L. E., Nunn, A. J., Peak, M., & Turner, M. A. (2022). Development and evaluation of an assessment of the age-appropriateness/inappropriateness of formulations used in children. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 44(6), 1394-1405. doi:10.1007/s11096-022-01478-5
Developing a More Tailored Approach to Patient and Public Involvement with Children and Families in Pediatric Clinical Research: Lessons Learned
Preston, J., Nafria, B., Ohmer, A., Gaillard, S., Dicks, P., West, L., & Turner, M. A. (2022). Developing a More Tailored Approach to Patient and Public Involvement with Children and Families in Pediatric Clinical Research: Lessons Learned. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 56(6), 948-963. doi:10.1007/s43441-022-00382-4
Health Equity in Pediatric Drug Development: Translating Aspiration into Operation
Folayan, M. O., Conway, M., Russo, C., Diniz, N., Jafta, L. P., Sam-Agudu, N. A., . . . Turner, M. A. (2022). Health Equity in Pediatric Drug Development: Translating Aspiration into Operation. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 56(6), 991-1003. doi:10.1007/s43441-022-00410-3
Implementation of a Centralized Pharmacovigilance System in Multi-Country European Clinical Trials: Points to Consider for Academic Sponsors and Lessons Learnt from EU-Response and Connect4Children Consortia
Landscape analysis for a neonatal disease progression model of bronchopulmonary dysplasia: Leveraging clinical trial experience and real-world data
Barrett, J. S., Pane, M. C., Knab, T., Roddy, W., Beusmans, J., Jordie, E., . . . Turner, M. (2022). Landscape analysis for a neonatal disease progression model of bronchopulmonary dysplasia: Leveraging clinical trial experience and real-world data. FRONTIERS IN PHARMACOLOGY, 13. doi:10.3389/fphar.2022.988974
European research networks to facilitate drug research in children
Turner, M. A., Cheng, K., de Wildt, S., Hildebrand, H., Attar, S., Rossi, P., . . . Giaquinto, C. (2022). European research networks to facilitate drug research in children. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 88(10), 4258-4266. doi:10.1111/bcp.14545
From paediatric formulations development to access: Advances made and remaining challenges
Litalien, C., Berube, S., Tuleu, C., Gilpin, A., Landry, E. K., Valentin, M., . . . Turner, M. A. (2022). From paediatric formulations development to access: Advances made and remaining challenges. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 88(10), 4349-4383. doi:10.1111/bcp.15293
Risk-proportionate approach to paediatric clinical trials: The legal requirements, challenges, and the way forward under the European Union Clinical Trials Regulation
Wan, M., Alessandrini, E., Brogan, P., Eleftheriou, D., Warris, A., Bruggemann, R., & Turner, M. (2022). Risk-proportionate approach to paediatric clinical trials: The legal requirements, challenges, and the way forward under the European Union Clinical Trials Regulation. CLINICAL TRIALS, 19(5), 573-578. doi:10.1177/17407745221093812
Parent co-Designed Drug Information for parents and Guardians Taking Neonates home (PADDINGToN) a mixed method approach to defining and evaluating information resources
Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses
McNaughton, A. L., Paton, R. S., Edmans, M., Youngs, J., Wellens, J., Phalora, P., . . . Thompson, C. P. (2022). Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses. JCI INSIGHT, 7(13). doi:10.1172/jci.insight.156372
Nephrotoxic drugs and renal function in preterm infants: are urinary biomarkers the answer?
McWilliam, S. J., Turner, M. A., & Davis, J. M. (2022). Nephrotoxic drugs and renal function in preterm infants: are urinary biomarkers the answer?. PEDIATRIC RESEARCH, 92(1), 22-24. doi:10.1038/s41390-022-02049-0
Calling for Unity, Solidarity, Continuity, and Access-Oriented Action in Times of War.
Buergi, B. R., Arawi, T., Asif, F., Aurich, B., Ching, S. L., Crawley, F. P., . . . Wiśniewski, A. (2022). Calling for Unity, Solidarity, Continuity, and Access-Oriented Action in Times of War.. Pharmaceutical medicine, 36(3), 147-151. doi:10.1007/s40290-022-00431-1
Rapid Point-of-Care Genotyping to Avoid Aminoglycoside-Induced Ototoxicity in Neonatal Intensive Care
McDermott, J. H., Mahaveer, A., James, R. A., Booth, N., Turner, M., Harvey, K. E., . . . Newman, W. G. (2022). Rapid Point-of-Care Genotyping to Avoid Aminoglycoside-Induced Ototoxicity in Neonatal Intensive Care. JAMA PEDIATRICS, 176(5), 486-492. doi:10.1001/jamapediatrics.2022.0187
WHO essential medicines for children 2011-2019: age-appropriateness of enteral formulations
Orubu, E. S. F., Duncan, J., Tuleu, C., Turner, M. A., & Nunn, A. (2022). WHO essential medicines for children 2011-2019: age-appropriateness of enteral formulations. ARCHIVES OF DISEASE IN CHILDHOOD, 107(4), 317-322. doi:10.1136/archdischild-2021-321831
Development of the PREMature Infant Index (PREMII™), a clinician-reported outcome measure assessing functional status of extremely preterm infants
Ward, R. M., Turner, M. A., Hansen-Pupp, I., Higginson, J., Vanya, M., Flood, E., . . . Sarda, S. P. (n.d.). Development of the PREMature Infant Index (PREMII™), a clinician-reported outcome measure assessing functional status of extremely preterm infants. The Journal of Maternal-Fetal & Neonatal Medicine, 1-10. doi:10.1080/14767058.2020.1735338
Assessing patent ductus arteriosus in preterm infants from standard neonatal intensive care monitoring
Kotidis, C., Wertheim, D., Weindling, M., Rabe, H., & Turner, M. A. (2022). Assessing patent ductus arteriosus in preterm infants from standard neonatal intensive care monitoring. EUROPEAN JOURNAL OF PEDIATRICS, 181(3), 1117-1124. doi:10.1007/s00431-021-04311-9
Neonatal sepsis: a systematic review of core outcomes from randomised clinical trials
Henry, C. J., Semova, G., Barnes, E., Cotter, I., Devers, T., Rafaee, A., . . . Molloy, E. J. (2022). Neonatal sepsis: a systematic review of core outcomes from randomised clinical trials. PEDIATRIC RESEARCH, 91(4), 735-742. doi:10.1038/s41390-021-01883-y
Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial
Hill, L. F., Clements, M. N., Turner, M. A., Dona, D., Lutsar, I., Jacqz-Aigrain, E., . . . Sharland, M. (2022). Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial. LANCET CHILD & ADOLESCENT HEALTH, 6(1), 49-59. doi:10.1016/S2352-4642(21)00305-9
Pharmacogenetics to Avoid Loss of Hearing (PALOH): A Prospective Observational Trial to Assess the Implementation of Rapid Genotyping to Avoid Aminoglycoside Induced Ototoxicity in Newborns
McDermott, J. H., Mahood, R., Stoddard, D., Ainsworth, S., Miele, G., Bruce, I., . . . Newman, W. G. (2022). Pharmacogenetics to Avoid Loss of Hearing (PALOH): A Prospective Observational Trial to Assess the Implementation of Rapid Genotyping to Avoid Aminoglycoside Induced Ototoxicity in Newborns. In EUROPEAN JOURNAL OF HUMAN GENETICS Vol. 30 (pp. 83). Retrieved from https://www.webofscience.com/
2021
Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants
Parker, E. P. K., Bronowski, C., Sindhu, K. N. C., Babji, S., Benny, B., Carmona-Vicente, N., . . . Iturriza-Gomara, M. (2021). Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants. NATURE COMMUNICATIONS, 12(1). doi:10.1038/s41467-021-27074-1
Early Impact of Severe Acute Respiratory Syndrome Coronavirus 2 on Pediatric Clinical Research: A Pan-European and Canadian Snapshot in Time.
Mantha, O. L., Flamein, F., Turner, M. A., Fernandes, R. M., Hankard, R., & Network of National Networks Study Group. (2021). Early Impact of Severe Acute Respiratory Syndrome Coronavirus 2 on Pediatric Clinical Research: A Pan-European and Canadian Snapshot in Time.. The Journal of pediatrics, 239, 67-73.e3. doi:10.1016/j.jpeds.2021.08.028
The culture of research communication in neonatal intensive care units: key stakeholder perspectives.
Degl, J., Discenza, D., Jackson, Y., Sorrells, K., & International Neonatal Consortium. (2021). The culture of research communication in neonatal intensive care units: key stakeholder perspectives.. Journal of perinatology : official journal of the California Perinatal Association, 41(12), 2702-2703. doi:10.1038/s41372-021-01221-4
Neonatal sepsis definitions from randomised clinical trials
Hayes, R., Hartnett, J., Semova, G., Murray, C., Murphy, K., Carroll, L., . . . Res, E. S. P. (2021). Neonatal sepsis definitions from randomised clinical trials. PEDIATRIC RESEARCH. doi:10.1038/s41390-021-01749-3
Development of Protein-Specific Analytical Methodologies to Evaluate Compatibility of Recombinant Human (rh)IGF-1/rhIGFBP-3 with Intravenous Medications Co-Administered to Neonates
Salamat-Miller, N., Qu, W., Chadwick, J. S., McPherson, C., Salinas, P. A., Turner, M., . . . Barton, N. (2021). Development of Protein-Specific Analytical Methodologies to Evaluate Compatibility of Recombinant Human (rh)IGF-1/rhIGFBP-3 with Intravenous Medications Co-Administered to Neonates. Journal of Pharmaceutical Sciences. doi:10.1016/j.xphs.2021.10.027
The culture of research communication in neonatal intensive care units: key stakeholder perspectives
Degl, J., Ariagno, R., Aschner, J., Beauman, S., Eklund, W., Faro, E., . . . Consortium, I. N. (2021). The culture of research communication in neonatal intensive care units: key stakeholder perspectives. JOURNAL OF PERINATOLOGY. doi:10.1038/s41372-021-01220-5
Spectrum, risk factors and outcomes of neurological complications of COVID-19
Russell, A. R., Hardwick, M., Jeyanantham, A., White, L., Deb, S., Burnside, G., . . . Galea, I. (2021). Spectrum, risk factors and outcomes of neurological complications of COVID-19. In JOURNAL OF THE NEUROLOGICAL SCIENCES Vol. 429. doi:10.1016/j.jns.2021.117807
The Induction with Foley OR Misoprostol (INFORM) Study dataset. A dataset of 602 women with hypertensive disease in pregnancy, in India, randomised to either Foley catheter or oral misoprostol for induction of labour.
Mundle, S., Bracken, H., Khedikar, V., Mulik, J., Faragher, B., Easterling, T., . . . Weeks, A. D. (2021). The Induction with Foley OR Misoprostol (INFORM) Study dataset. A dataset of 602 women with hypertensive disease in pregnancy, in India, randomised to either Foley catheter or oral misoprostol for induction of labour.. BMC research notes, 14(1), 355. doi:10.1186/s13104-021-05772-9
The urgent need for research coordination to advance knowledge on COVID-19 in children
Bourgeois, F. T., Avillach, P., & Turner, M. A. (n.d.). The urgent need for research coordination to advance knowledge on COVID-19 in children. Pediatric Research. doi:10.1038/s41390-020-01259-8
Oral Misoprostol alone versus oral misoprostol followed by oxytocin for labour induction in women with hypertension in pregnancy (MOLI): protocol for a randomised controlled trial
Bracken, H., Lightly, K., Mundle, S., Kerr, R., Faragher, B., Easterling, T., . . . Weeks, A. (2021). Oral Misoprostol alone versus oral misoprostol followed by oxytocin for labour induction in women with hypertension in pregnancy (MOLI): protocol for a randomised controlled trial. BMC PREGNANCY AND CHILDBIRTH, 21(1). doi:10.1186/s12884-021-04009-8
Spectrum, Risk Factors, and Outcomes of Neurological and Psychiatric Complications of COVID-19: A UK-Wide Cross-Sectional Surveillance Study
Russell, A. R., Hardwick, M., Jeyanantham, A., White, L., Deb, S., Burnside, G., . . . Galea, I. (2021). Spectrum, Risk Factors, and Outcomes of Neurological and Psychiatric Complications of COVID-19: A UK-Wide Cross-Sectional Surveillance Study. doi:10.2139/ssrn.3767901
Neonatal sepsis: need for consensus definition, collaboration and core outcomes (vol 88, pg 2, 2020)
Molloy, E. J., Wynn, J. L., Bliss, J., Koenig, J. M., Keij, F. M., McGovern, M., . . . Reiss, I. K. M. (2021). Neonatal sepsis: need for consensus definition, collaboration and core outcomes (vol 88, pg 2, 2020). PEDIATRIC RESEARCH, 90(1), 232. doi:10.1038/s41390-020-01221-8
Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19 a UK-wide cross-sectional surveillance study
Russell, A. L. R., Hardwick, M., Jeyanantham, A., White, L. M., Deb, S., Burnside, G., . . . Galea, I. (2021). Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19 a UK-wide cross-sectional surveillance study. BRAIN COMMUNICATIONS, 3(3). doi:10.1093/braincomms/fcab168
Pharmacogenetics to Avoid Loss of Hearing (PALOH) trial: a protocol for a prospective observational implementation trial
McDermott, J. H., Mahood, R., Stoddard, D., Mahaveer, A., Turner, M. A., Corry, R., . . . Newman, W. G. (2021). Pharmacogenetics to Avoid Loss of Hearing (PALOH) trial: a protocol for a prospective observational implementation trial. BMJ OPEN, 11(6). doi:10.1136/bmjopen-2020-044457
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Horby, P. W., Landray, M. J., & Grp, R. E. C. O. V. E. R. Y. C. (2021). Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. LANCET, 397(10289), 2049-2059. doi:10.1016/S0140-6736(21)00897-7
Challenges of a simplified opt-out consent process in a neonatal randomised controlled trial: qualitative study of parents' and health professionals' views and experiences.
McLeish, J., Alderdice, F., Robberts, H., Cole, C., Dorling, J., Gale, C., & Members of the WHEAT trial development group. (2021). Challenges of a simplified opt-out consent process in a neonatal randomised controlled trial: qualitative study of parents' and health professionals' views and experiences.. Archives of disease in childhood. Fetal and neonatal edition, 106(3), 244-250. doi:10.1136/archdischild-2020-319545
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby, P. W., & Landray, M. J. (2021). Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. LANCET, 397(10285), 1637-1645. Retrieved from https://www.webofscience.com/
Recommendations by the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) Working Group on preparedness of clinical trials about paediatric medicines process.
Siapkara, A., Fracasso, C., Egger, G. F., Rizzari, C., Trasorras, C. S., Athanasiou, D., . . . Working Group Membership. (2021). Recommendations by the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) Working Group on preparedness of clinical trials about paediatric medicines process.. Archives of Disease in Childhood. doi:10.1136/archdischild-2020-321433
Prospective identification and causality evaluation of suspected adverse drug reactions in neonates
Roberts, E. K., Hawcutt, D. B., & Turner, M. A. (2021). Prospective identification and causality evaluation of suspected adverse drug reactions in neonates. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 87(3), 1541-1546. doi:10.1111/bcp.14485
The conect4children (c4c) Consortium: Potential for Improving European Clinical Research into Medicines for Children
Turner, M. A., Hildebrand, H., Fernandes, R. M., de Wildt, S. N., Mahler, F., Hankard, R., . . . Giaquinto, C. (2021). The conect4children (c4c) Consortium: Potential for Improving European Clinical Research into Medicines for Children. PHARMACEUTICAL MEDICINE, 35(2), 71-79. doi:10.1007/s40290-020-00373-6
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby, P. W., Roddick, A., Spata, E., Staplin, N., Emberson, J., Pessoa-Amorim, G., . . . Yates, H. (2021). Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. LANCET, 397(10274), 605-612. doi:10.1016/S0140-6736(21)00149-5
2020
Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants: a prospective cohort study
Parker, E., Bronowski, C., Sindhu, K. N., Babji, S., Benny, B., Carmona-Vicente, N., . . . Iturriza-Gómara, M. (2020). Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants: a prospective cohort study. doi:10.1101/2020.11.02.20224576
Study protocol: azithromycin therapy for chronic lung disease of prematurity (AZTEC)-a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants
Lowe, J., Gillespie, D., Hubbard, M., Zhang, L., Kirby, N., Pickles, T., . . . Kotecha, S. (2020). Study protocol: azithromycin therapy for chronic lung disease of prematurity (AZTEC)-a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants. BMJ OPEN, 10(10). doi:10.1136/bmjopen-2020-041528
G355(P) Can bedside blood spot ammonia testing be a useful tool for predicting the adequacy of parenteral nutrition arginine intake in very preterm infants?
Burgess, L., Premakumar, C., Flanagan, B., Turner, M., & Morgan, C. (2020). G355(P) Can bedside blood spot ammonia testing be a useful tool for predicting the adequacy of parenteral nutrition arginine intake in very preterm infants?. In British association for paediatric nephrology. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health. doi:10.1136/archdischild-2020-rcpch.303
Evaluating preterm care across Europe using the eNewborn European Network database
Haumont, D., Modi, N., Saugstad, O. D., Antetere, R., Cuong, N., Turner, M., . . . Aelvoet, W. (2020). Evaluating preterm care across Europe using the eNewborn European Network database. PEDIATRIC RESEARCH, 88(3), 484-495. doi:10.1038/s41390-020-0769-x
Challenges in developing a consensus definition of neonatal sepsis
McGovern, M., Giannoni, E., Kuester, H., Turner, M. A., van den Hoogen, A., Bliss, J. M., . . . Molloy, E. J. (2020). Challenges in developing a consensus definition of neonatal sepsis. PEDIATRIC RESEARCH, 88(1), 14-26. doi:10.1038/s41390-020-0785-x
Neonatal sepsis: need for consensus definition, collaboration and core outcomes
Molloy, E. J., Wynn, J. L., Bliss, J., Koenig, J. M., Keij, F. M., McGovern, M., . . . Reiss, I. K. M. (2020). Neonatal sepsis: need for consensus definition, collaboration and core outcomes. PEDIATRIC RESEARCH, 88(1), 2-4. doi:10.1038/s41390-020-0850-5
Method of Blood Pressure Measurement in Neonates and Infants: A Systematic Review and Analysis
Dionne, J. M., Bremner, S. A., Baygani, S. K., Batton, B., Ergenekon, E., Bhatt-Mehta, V., . . . Rabe, H. (2020). Method of Blood Pressure Measurement in Neonates and Infants: A Systematic Review and Analysis. JOURNAL OF PEDIATRICS, 221, 23-+. doi:10.1016/j.jpeds.2020.02.072
Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European society for Developmental Perinatal and Pediatric Pharmacology
Schrier, L., Hadjipanayis, A., Stiris, T., Ross-Russell, R. I., Valiulis, A., Turner, M. A., . . . van den Anker, J. (2020). Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European society for Developmental Perinatal and Pediatric Pharmacology. EUROPEAN JOURNAL OF PEDIATRICS, 179(5), 839-847. doi:10.1007/s00431-019-03556-9
An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial
Hill, L. F., Turner, M. A., Lutsar, I., Heath, P. T., Hardy, P., Linsell, L., . . . Sharland, M. (2020). An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial. TRIALS, 21(1). doi:10.1186/s13063-020-4184-8
Standardizing Safety Assessment and Reporting for Neonatal Clinical Trials
Davis, J. M., Baer, G. R., McCune, S., Klein, A., Sato, J., Fabbri, L., . . . Portman, R. (2020). Standardizing Safety Assessment and Reporting for Neonatal Clinical Trials. JOURNAL OF PEDIATRICS, 219, 243-+. doi:10.1016/j.jpeds.2019.09.060
Neurodevelopmental Outcomes at 42 Months After Thyroxine Supplementation in Infants Below 28 Weeks' Gestation: A Randomized Controlled Trial.
Ng, S. M., Turner, M. A., & Weindling, A. M. (2020). Neurodevelopmental Outcomes at 42 Months After Thyroxine Supplementation in Infants Below 28 Weeks' Gestation: A Randomized Controlled Trial.. Thyroid : official journal of the American Thyroid Association. doi:10.1089/thy.2019.0293
Characterization of Circulating Clostridium difficile Strains, Host Response and Intestinal Microbiome in Hospitalized Children With Diarrhea
Lees, E. A., Carrol, E. D., Ellaby, N. A. F., Roberts, P., Corless, C. E., Lenzi, L., . . . Pirmohamed, M. (2020). Characterization of Circulating Clostridium difficile Strains, Host Response and Intestinal Microbiome in Hospitalized Children With Diarrhea. The Pediatric infectious disease journal, 39(3), 221-228. doi:10.1097/inf.0000000000002559
Genetic background of high blood pressure is associated with reduced mortality in premature neonates
Goepel, W., Mueller, M., Rabe, H., Borgmann, J., Rausch, T. K., Faust, K., . . . Herting, E. (2020). Genetic background of high blood pressure is associated with reduced mortality in premature neonates. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 105(2), F184-F189. doi:10.1136/archdischild-2019-317131
Survey by TEDDY European Network of Excellence for Paediatric Clinical Research demonstrates potential for Europe-wide trials
Ruggieri, L., Bonifazi, D., Landi, A., Bonifazi, F., Bartoloni, F., Costello, M., . . . Ceci, A. (2020). Survey by TEDDY European Network of Excellence for Paediatric Clinical Research demonstrates potential for Europe-wide trials. ACTA PAEDIATRICA, 109(3), 607-612. doi:10.1111/apa.15020
Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early‐onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo‐controlled double‐blind trial
Khalil, A., Sharp, A. N., Cornforth, C., Jackson, R., Mousa, H., Stock, S., . . . Alfirevic, Z. (2020). Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early‐onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo‐controlled double‐blind trial. Ultrasound in Obstetrics and Gynecology, 55(2), 198-209. doi:10.1002/uog.20851
Big Data in the Assessment of Pediatric Medication Safety
McMahon, A. W., Cooper, W. O., Brown, J. S., Carleton, B., Doshi-Velez, F., Kohane, I., . . . Califf, R. M. (2020). Big Data in the Assessment of Pediatric Medication Safety. PEDIATRICS, 145(2). doi:10.1542/peds.2019-0562
2019
Standardising neonatal and paediatric antibiotic clinical trial design and conduct: the PENTA-ID network view
Folgori, L., Lutsar, I., Standing, J. F., Walker, A. S., Roilides, E., Zaoutis, T. E., . . . Sharland, M. (2019). Standardising neonatal and paediatric antibiotic clinical trial design and conduct: the PENTA-ID network view. BMJ OPEN, 9(12). doi:10.1136/bmjopen-2019-032592
Top research priorities for preterm birth: results of a prioritisation partnership between people affected by preterm birth and healthcare professionals
Oliver, S., Uhm, S., Duley, L., Crowe, S., David, A. L., James, C. P., . . . Deshpande, S. (2019). Top research priorities for preterm birth: results of a prioritisation partnership between people affected by preterm birth and healthcare professionals. BMC PREGNANCY AND CHILDBIRTH, 19(1). doi:10.1186/s12884-019-2654-3
Development of a neonatal adverse event severity scale through a Delphi consensus approach
Salaets, T., Turner, M. A., Short, M., Ward, R. M., Hokuto, I., Ariagno, R. L., . . . Zeldis, S. (2019). Development of a neonatal adverse event severity scale through a Delphi consensus approach. ARCHIVES OF DISEASE IN CHILDHOOD, 104(12), 1167-+. doi:10.1136/archdischild-2019-317399
Medicines prescription patterns in European neonatal units
Mesek, I., Nellis, G., Lass, J., Metsvaht, T., Varendi, H., Visk, H., . . . Lutsar, I. (2019). Medicines prescription patterns in European neonatal units. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 41(6), 1578-1591. doi:10.1007/s11096-019-00923-2
Relationship between arginine intake in parenteral nutrition and preterm neonatal population plasma arginine concentrations: a systematic review
Premakumar, C. M., Turner, M. A., & Morgan, C. (2019). Relationship between arginine intake in parenteral nutrition and preterm neonatal population plasma arginine concentrations: a systematic review. NUTRITION REVIEWS, 77(12), 878-889. doi:10.1093/nutrit/nuz049
Assessment of long-term neurodevelopmental outcome following trials of medicinal products in newborn infants
Marlow, N., Doyle, L. W., Anderson, P., Johnson, S., Bhatt-Mehta, V., Natalucci, G., . . . Turner, M. A. (2019). Assessment of long-term neurodevelopmental outcome following trials of medicinal products in newborn infants. PEDIATRIC RESEARCH, 86(5), 567-572. doi:10.1038/s41390-019-0526-1
Suspected adverse drug reactions reported for Brazilian children: cross‐sectional study
Lima, E. D. C., de Matos, G. C., de L. Vieira, J. M., da C.R. Gonçalves, I. C., Cabral, L. M., & Turner, M. A. (2019). Suspected adverse drug reactions reported for Brazilian children: cross‐sectional study. Jornal de Pediatria (Versão em Português), 95(6), 682-688. doi:10.1016/j.jpedp.2018.05.016
A Prediction Model for Short-Term Neonatal Outcomes in Severe Early-Onset Fetal Growth Restriction
Sharp, A., Jackson, R., Cornforth, C., Harrold, J., Turner, M. A., Kenny, L., . . . Alfirevic, Z. (2019). A Prediction Model for Short-Term Neonatal Outcomes in Severe Early-Onset Fetal Growth Restriction. European Journal of Obstetrics and Gynecology and Reproductive Biology, 241, 109-118. doi:10.1016/j.ejogrb.2019.08.007
Dose-linearity of the pharmacokinetics of an intravenous [<SUP>14</SUP>C]midazolam microdose in children
van Groen, B. D., Vaes, W. H., Park, B. K., Krekels, E. H. J., van Duijn, E., Korgvee, L. -T., . . . Turner, M. A. (2019). Dose-linearity of the pharmacokinetics of an intravenous [<SUP>14</SUP>C]midazolam microdose in children. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 85(10), 2332-2340. doi:10.1111/bcp.14047
The WHEAT pilot trial-WithHolding Enteral feeds Around packed red cell Transfusion to prevent necrotising enterocolitis in preterm neonates: a multicentre, electronic patient record (EPR), randomised controlled point-of-care pilot trial
Gale, C., Modi, N., Jawad, S., Culshaw, L., Dorling, J., Bowler, U., . . . Juszczak, E. (2019). The WHEAT pilot trial-WithHolding Enteral feeds Around packed red cell Transfusion to prevent necrotising enterocolitis in preterm neonates: a multicentre, electronic patient record (EPR), randomised controlled point-of-care pilot trial. BMJ OPEN, 9(9). doi:10.1136/bmjopen-2019-033543
Inequalities and stillbirth in the UK: a meta-narrative review
Kingdon, C., Roberts, D., Turner, M. A., Storey, C., Crossland, N., Finlayson, K. W., & Downe, S. (2019). Inequalities and stillbirth in the UK: a meta-narrative review. BMJ OPEN, 9(9). doi:10.1136/bmjopen-2019-029672
Very low-dose dexamethasone to facilitate extubation of preterm babies at risk of bronchopulmonary dysplasia: the MINIDEX feasibility RCT
Yates, H., Chiocchia, V., Linsell, L., Orsi, N., Juszczak, E., Johnson, K., . . . Turner, M. (2019). Very low-dose dexamethasone to facilitate extubation of preterm babies at risk of bronchopulmonary dysplasia: the MINIDEX feasibility RCT. Efficacy and Mechanism Evaluation. doi:10.3310/eme06080
Necrotizing Enterocolitis: Using Regulatory Science and Drug Development to Improve Outcomes
Caplan, M. S., Underwood, M. A., Modi, N., Patel, R., Gordon, P. V., Sylvester, K. G., . . . West, A. (2019). Necrotizing Enterocolitis: Using Regulatory Science and Drug Development to Improve Outcomes. JOURNAL OF PEDIATRICS, 212, 208-+. doi:10.1016/j.jpeds.2019.05.032
Transcriptomics and Metabolomics Analyses of the Effect of Parenteral Nutrition Arginine Supplementation in Very Preterm Infants
Burgess, L., Flanagan, B., Caamano-Gutierrez, E., Wright, H., Slupsky, C., Turner, M., & Morgan, C. (2019). Transcriptomics and Metabolomics Analyses of the Effect of Parenteral Nutrition Arginine Supplementation in Very Preterm Infants. In American Journal of Perinatology. Thieme Medical Publishers. doi:10.1055/s-0039-1693264
O20 Dose-linearity of the pharmacokinetics of an intravenous [<sup>14</sup>C]midazolam microdose in children
van Groen, B. D., Vaes, W. H. J., Park, B. K., Krekels, E. H. J., van Duijn, E., Kõrgvee, L. -T., . . . Turner, M. A. (2019). O20 Dose-linearity of the pharmacokinetics of an intravenous [<sup>14</sup>C]midazolam microdose in children. Archives of Disease in Childhood, 104(6), e9.1-e9. doi:10.1136/archdischild-2019-esdppp.20
Adrenal function of extremely premature infants in the first 5 days after birth
Ng, S. M., Ogundiya, A., Didi, M., & Turner, M. A. (2019). Adrenal function of extremely premature infants in the first 5 days after birth. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 32(4), 363-367. doi:10.1515/jpem-2018-0417
Challenges in Designing Clinical Trials to Test New Drugs in the Pregnant Woman and Fetus
Turner, M. A., Kenny, L., & Alfirevic, Z. (2019). Challenges in Designing Clinical Trials to Test New Drugs in the Pregnant Woman and Fetus. Clinics in Perinatology. doi:10.1016/j.clp.2019.02.015
Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction
Sharp, A., Cornforth, C., Jackson, R., Harrold, J., Turner, M. A., Kenny, L., . . . Alfirevic, Z. (2019). Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction. LANCET CHILD & ADOLESCENT HEALTH, 3(3), E2-E3. doi:10.1016/S2352-4642(19)30020-3
rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial
Ley, D., Hallberg, B., Hansen-Pupp, I., Dani, C., Ramenghi, L. A., Marlow, N., . . . Hellström, A. (2019). rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial. Journal of Pediatrics, 206, 56-65.e8. doi:10.1016/j.jpeds.2018.10.033
Extreme Premature Small for Gestational Age Infants Have Appropriate Catch-up Growth at Term Equivalence Compared with Extreme Premature Appropriate for Gestational Age Infants
Ng, S. M., Pintus, D., & Turner, M. A. (2019). Extreme Premature Small for Gestational Age Infants Have Appropriate Catch-up Growth at Term Equivalence Compared with Extreme Premature Appropriate for Gestational Age Infants. JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 11(1), 104-108. doi:10.4274/jcrpe.galenos.2018.2018.0162
Prescribing Medicines for Children
Sharland, M. (2019). Prescribing Medicines for Children.
Extreme Premature Small For Gestational Age Infants Have Appropriate Catch-Up Growth At Term Equivalence Compared With Extreme Premature Appropriate For Gestational Age Infants
Ng, S. M., Pintus, D., & Turner, M. A. (n.d.). Extreme Premature Small For Gestational Age Infants Have Appropriate Catch-Up Growth At Term Equivalence Compared With Extreme Premature Appropriate For Gestational Age Infants. Journal of Clinical Research in Pediatric Endocrinology. doi:10.4274/jcrpe.0162
Diagnosing and Preventing Hearing Loss in the Genomic Age
McDermott, J. H., Molina-Ramirez, L. P., Bruce, I. A., Mahaveer, A., Turner, M., Miele, G., . . . Newman, W. G. (2019). Diagnosing and Preventing Hearing Loss in the Genomic Age. TRENDS IN HEARING, 23. doi:10.1177/2331216519878983
Validity of Biomarkers of Early Circulatory Impairment to Predict Outcome: A Retrospective Analysis
Carmen Bravo, M., Lopez-Ortego, P., Sanchez, L., Madero, R., Cabanas, F., Koch, A., . . . Toma, A. (2019). Validity of Biomarkers of Early Circulatory Impairment to Predict Outcome: A Retrospective Analysis. FRONTIERS IN PEDIATRICS, 7. doi:10.3389/fped.2019.00212
2018
Sharing Data to Accelerate Medicine Development and Improve Neonatal Care: Data Standards and Harmonized Definitions
Costeloe, K., Turner, M. A., Padula, M. A., Shah, P. S., Modi, N., Soll, R., . . . Hudson, L. D. (2018). Sharing Data to Accelerate Medicine Development and Improve Neonatal Care: Data Standards and Harmonized Definitions. JOURNAL OF PEDIATRICS, 203, 437-+. doi:10.1016/j.jpeds.2018.07.082
Drug prescription pattern in European neonatal units
428. Trials in low-resource settings: the INFORM study (oral misoprostol versus balloon induction in women with PIH or pre-eclampsia)
Mundle, S., Bracken, H., Khedikar, V., Mulik, J., Faragher, B., Easterling, T., . . . Weeks, A. D. (2018). 428. Trials in low-resource settings: the INFORM study (oral misoprostol versus balloon induction in women with PIH or pre-eclampsia). Pregnancy Hypertension, 13, S9. doi:10.1016/j.preghy.2018.08.029
81. Maternal cardiovascular changes secondary to sildenafil intake in pregnancies complicated by severe fetal growth restriction: STRIDER trial
Khalil, A., Sharp, A., Cornforth, C., Jackson, R., Mousa, H., Stock, S., . . . Alfirevic, Z. (2018). 81. Maternal cardiovascular changes secondary to sildenafil intake in pregnancies complicated by severe fetal growth restriction: STRIDER trial. Pregnancy Hypertension, 13, S70. doi:10.1016/j.preghy.2018.08.207
OP19.10: Maternal cardiovascular changes secondary to sildenafil intake in pregnancies complicated by severe fetal growth restriction: STRIDER trial
Khalil, A., Sharp, A., Cornforth, C., Jackson, R., Mousa, H., Stock, S., . . . Alfirevic, Z. (2018). OP19.10: Maternal cardiovascular changes secondary to sildenafil intake in pregnancies complicated by severe fetal growth restriction: STRIDER trial. Ultrasound in Obstetrics & Gynecology, 52(S1), 125. doi:10.1002/uog.19574
Placental Growth Factor informed management of suspected pre-eclampsia or fetal growth restriction: The MAPPLE cohort study
Sharp, A., Chappell, L. C., Dekker, G., Pelletier, S., Garnier, Y., Zeren, O., . . . Alfirevic, Z. (2018). Placental Growth Factor informed management of suspected pre-eclampsia or fetal growth restriction: The MAPPLE cohort study. PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 14, 228-233. doi:10.1016/j.preghy.2018.03.013
Suspected adverse drug reactions reported for Brazilian children: cross-sectional study.
Lima, E. D. C., Matos, G. C. D., Vieira, J. M. D. L., Gonçalves, I. C. D. C. R., Cabral, L. M., & Turner, M. A. (2018). Suspected adverse drug reactions reported for Brazilian children: cross-sectional study.. Jornal de pediatria. doi:10.1016/j.jped.2018.05.019
Foley Catheterization Versus Oral Misoprostol for Induction of Labour in Hypertensive Women in India (INFORM): A Multicenter, Open-label, Randomized Controlled Trial
Mundle, S., Bracken, H., Khedikar, V., Mulik, J., Faragher, B., Easterling, T., . . . Weeks, A. D. (2018). Foley Catheterization Versus Oral Misoprostol for Induction of Labour in Hypertensive Women in India (INFORM): A Multicenter, Open-label, Randomized Controlled Trial. Obstetric Anesthesia Digest, 38(2), 101-102. doi:10.1097/01.aoa.0000532296.83741.0c
Foley catheter vs. oral misoprostol to induce labour among hypertensive women in India: a cost-consequence analysis alongside a clinical trial
Leigh, S., Granby, P., Haycox, A., Mundle, S., Bracken, H., Khedikar, V., . . . Weeks, A. D. (2018). Foley catheter vs. oral misoprostol to induce labour among hypertensive women in India: a cost-consequence analysis alongside a clinical trial. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 125(13), 1734-1742. doi:10.1111/1471-0528.15285
Accuracy of intravenous and enteral preparations involving small volumes for paediatric use: a review
Ainscough, L. P., Ford, J. L., Morecroft, C. W., Peak, M., Turner, M. A., Nunn, A. J., & Roberts, M. (2018). Accuracy of intravenous and enteral preparations involving small volumes for paediatric use: a review. EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 25(2), 66-71. doi:10.1136/ejhpharm-2016-001117
Challenges and strategies to facilitate formulation development of pediatric drug products: Safety qualification of excipients
Buckley, L. A., Salunke, S., Thompson, K., Baer, G., Fegley, D., & Turner, M. A. (2018). Challenges and strategies to facilitate formulation development of pediatric drug products: Safety qualification of excipients. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 536(2), 563-569. doi:10.1016/j.ijpharm.2017.07.042
Challenges in the assessment of adverse drug reactions in children and neonates
Bracken, L., Nunn, A., Peak, M., & Turner, M. (2018). Challenges in the assessment of adverse drug reactions in children and neonates. Adverse Drug Reaction Bulletin, 308(1), 1191-1194. doi:10.1097/fad.0000000000000030
Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial
Sharp, A., Cornforth, C., Turner, M. A., Harrold, J., Kenny, L. C., Jackson, R., . . . Alfirevic, Z. (2018). Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial. Lancet Child and Adolescent Health, 2(2), 93-102. doi:10.1016/S2352-4642(17)30173-6
Foley Catheterisation Versus Oral Misoprostol for Induction of Labour in Hypertensive Women in India (INFORM): A Multicentre, Open-Label, Randomised Controlled Trial
Mundle, S., Bracken, H., Khedikar, V., Mulik, J., Faragher, B., Easterling, T., . . . Weeks, A. D. (2018). Foley Catheterisation Versus Oral Misoprostol for Induction of Labour in Hypertensive Women in India (INFORM): A Multicentre, Open-Label, Randomised Controlled Trial. OBSTETRICAL & GYNECOLOGICAL SURVEY, 73(1), 3-5. doi:10.1097/01.ogx.0000527997.68769.0f
IS AN INTRAVENOUS [14C]MIDAZOLAM MICRODOSE DOSE-LINEAR IN CHILDREN? RESULTS OF A PILOT STUDY.
van Groen, B. D., Park, B. K., Mooij, M. G., Vaes, W., Orgvee, L. -T. K., Maruszak, W., . . . Turner, M. A. (2018). IS AN INTRAVENOUS [14C]MIDAZOLAM MICRODOSE DOSE-LINEAR IN CHILDREN? RESULTS OF A PILOT STUDY.. In CLINICAL PHARMACOLOGY & THERAPEUTICS Vol. 103 (pp. S53). Retrieved from https://www.webofscience.com/
Industry and Patient Perspectives on Child Participation in Clinical Trials: The Pediatric Assent Initiative Survey Report
Lombardi, D., Squires, L., Sjostedt, P., Eichler, I., Turner, M. A., & Thompson, C. (2018). Industry and Patient Perspectives on Child Participation in Clinical Trials: The Pediatric Assent Initiative Survey Report. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 52(1), 29-37. doi:10.1177/2168479017716490
Maternal cardiovascular changes secondary to sildenafil intake in pregnancies complicated by severe fetal growth restriction: STRIDER trial
Khalil, A., Sharp, A., Cornforth, C., Jackson, R., Mousa, H., Stock, S., . . . Alfirevic, Z. (2018). Maternal cardiovascular changes secondary to sildenafil intake in pregnancies complicated by severe fetal growth restriction: STRIDER trial. In BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY Vol. 125 (pp. 25). Retrieved from https://www.webofscience.com/
2017
STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials
Pels, A., Kenny, L. C., Alfirevic, Z., Baker, P. N., von Dadelszen, P., Gluud, C., . . . Groom, K. M. (2017). STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials. BMC PREGNANCY AND CHILDBIRTH, 17. doi:10.1186/s12884-017-1594-z
Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development
Steinhorn, R., Davis, J. M., Göpel, W., Jobe, A., Abman, S., Laughon, M., . . . Turner, M. A. (2017). Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development. Journal of Pediatrics, 191, 15-21.e1. doi:10.1016/j.jpeds.2017.08.006
Ultrasound Measurements of Thyroid Gland Volume at 36 Weeks' Corrected Gestational Age in Extremely Preterm Infants Born before 28 Weeks' Gestation
Ng, S. M., Turner, M. A., & Avula, S. (2017). Ultrasound Measurements of Thyroid Gland Volume at 36 Weeks' Corrected Gestational Age in Extremely Preterm Infants Born before 28 Weeks' Gestation. EUROPEAN THYROID JOURNAL, 7(1), 21-26. doi:10.1159/000481857
A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome
Sweet, D. G., Turner, M. A., Straňák, Z., Plavka, R., Clarke, P., Stenson, B. J., . . . Speer, C. P. (2017). A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome. Archives of disease in childhood. Fetal and neonatal edition, 102(6), F497-F503. doi:10.1136/archdischild-2017-312722
Biomarkers of hepatic injury and function in neonatal hypoxic ischemic encephalopathy and with therapeutic hypothermia
Muniraman, H., Gardner, D., Skinner, J., Paweletz, A., Vayalakkad, A., Chee, Y. H., . . . Clarke, P. (2017). Biomarkers of hepatic injury and function in neonatal hypoxic ischemic encephalopathy and with therapeutic hypothermia. EUROPEAN JOURNAL OF PEDIATRICS, 176(10), 1295-1303. doi:10.1007/s00431-017-2956-2
Biomarkers of hepatic injury and function in neonatal hypoxic ischemic encephalopathy and with therapeutic hypothermia (vol 176, pg 1295, 2017)
Muniraman, H., Gardner, D., Skinner, J., Paweletz, A., Vayalakkad, A., Chee, Y. H., . . . Clarke, P. (2017). Biomarkers of hepatic injury and function in neonatal hypoxic ischemic encephalopathy and with therapeutic hypothermia (vol 176, pg 1295, 2017). EUROPEAN JOURNAL OF PEDIATRICS, 176(10), 1305-1306. doi:10.1007/s00431-017-2980-2
Enrollment of Neonates in More Than One Clinical Trial
Davis, J. M., Baer, G. R., Portman, R., Nelson, R., Storari, L., Aranda, J. V., . . . Allegaert, K. (2017). Enrollment of Neonates in More Than One Clinical Trial. CLINICAL THERAPEUTICS, 39(10), 1959-1969. doi:10.1016/j.clinthera.2017.09.006
Frameworks for Evaluating Medicines in Children
Turner, M. A., & Hirschfeld, S. (2017). Frameworks for Evaluating Medicines in Children. CLINICAL THERAPEUTICS, 39(10), 1949-1958. doi:10.1016/j.clinthera.2017.09.003
O-24 Adrin 1 methodology study: adverse drug reactions in neonates: what are the best ways to evaluate suspected adverse drug reactions in neonates?
Roberts., Hawcutt., & Turner. (2017). O-24 Adrin 1 methodology study: adverse drug reactions in neonates: what are the best ways to evaluate suspected adverse drug reactions in neonates?. In Archives of Disease in Childhood Vol. 102 (pp. A11.2-A11). BMJ. doi:10.1136/archdischild-2017-esdppp.24
PP-34 Adverse drug reactions in neonates: comparing retrospective spontaneous yellow card reports to prospectively collected reports
Roberts., Hawcutt., & Turner. (2017). PP-34 Adverse drug reactions in neonates: comparing retrospective spontaneous yellow card reports to prospectively collected reports. In Archives of Disease in Childhood Vol. 102 (pp. A28.1-A28). BMJ. doi:10.1136/archdischild-2017-esdppp.59
Roles of Clinical Research Networks in Pediatric Drug Development
Turner, M. A., Attar, S., de Wildt, S. N., Vassal, G., Mangiarini, L., & Giaquinto, C. (2017). Roles of Clinical Research Networks in Pediatric Drug Development. CLINICAL THERAPEUTICS, 39(10), 1939-1948. doi:10.1016/j.clinthera.2017.09.001
OC01.05: STRIDER UK: a randomised controlled trial of sildenafil therapy in dismal prognosis early‐onset intrauterine growth restriction
Sharp, A., Comforth, C., Jackson, R., Turner, M., Kenny, L., Baker, P., . . . Alfirevic, Z. (2017). OC01.05: STRIDER UK: a randomised controlled trial of sildenafil therapy in dismal prognosis early‐onset intrauterine growth restriction. Ultrasound in Obstetrics & Gynecology, 50(S1), 3. doi:10.1002/uog.17574
Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India (INFORM): a multicentre, open-label, randomised controlled trial
Mundle, S., Bracken, H., Khedikar, V., Mulik, J., Faragher, B., Easterling, T., . . . Weeks, A. D. (2017). Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India (INFORM): a multicentre, open-label, randomised controlled trial. LANCET, 390(10095), 669-680. doi:10.1016/S0140-6736(17)31367-3
Regulatory Science in Neonates A Framework That Supports Evidence-Based Drug Therapy
Turner, M., Portman, R. J., & Davis, J. M. (2017). Regulatory Science in Neonates A Framework That Supports Evidence-Based Drug Therapy. JAMA PEDIATRICS, 171(8), 721-722. doi:10.1001/jamapediatrics.2017.1360
Screening methods for obstructive sleep apnoea in severely obese pregnant women
Longworth, H., McCallin, K., Narayanan, R. P., Turner, M. A., Quenby, S., Rycroft, D., . . . Wilding, J. P. H. (2017). Screening methods for obstructive sleep apnoea in severely obese pregnant women. CLINICAL OBESITY, 7(4), 239-244. doi:10.1111/cob.12196
OP 2 Placental growth factor informed management of suspected pre-eclampsia and/or fetal growth restriction – The MAPPLE cohort study
Sharp, A., Chappell, L., Dekker, G., Pelletier, S., Garnier, Y., Zeren, O., . . . Alfirevic, Z. (2017). OP 2 Placental growth factor informed management of suspected pre-eclampsia and/or fetal growth restriction – The MAPPLE cohort study. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health, 9, 9-10. doi:10.1016/j.preghy.2017.07.025
Optimising the use of medicines to reduce acute kidney injury in children and babies
Oni, L., Hawcutt, D. B., Turner, M. A., Beresford, M. W., McWilliam, S., Barton, C., . . . Antoine, D. J. (2017). Optimising the use of medicines to reduce acute kidney injury in children and babies. Pharmacology and Therapeutics, 174, 55-62. doi:10.1016/j.pharmthera.2017.02.018
Safety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonates
Ward, R. M., Benjamin, D., Barrett, J. S., Allegaert, K., Portman, R., Davis, J. M., & Turner, M. A. (2017). Safety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonates. PEDIATRIC RESEARCH, 81(5), 692-711. doi:10.1038/pr.2016.221
Impact of maternal antibodies and infant gut microbiota on the immunogenicity of rotavirus vaccines in African, Indian and European infants: protocol for a prospective cohort study
Sindhu, K. N. C., Cunliffe, N., Peak, M., Turner, M., Darby, A., Grassly, N., . . . Kang, G. (2017). Impact of maternal antibodies and infant gut microbiota on the immunogenicity of rotavirus vaccines in African, Indian and European infants: protocol for a prospective cohort study. BMJ OPEN, 7(3). doi:10.1136/bmjopen-2017-016577
Neonatal listeriosis in the UK 2004-2014
Sapuan, S., Kortsalioudaki, C., Anthony, M., Chang, J., Embleton, N. D., Geethanath, R. M., . . . Vergnano, S. (2017). Neonatal listeriosis in the UK 2004-2014. JOURNAL OF INFECTION, 74(3), 236-242. doi:10.1016/j.jinf.2016.11.007
A systematic review of the use of dosage form manipulation to obtain required doses to inform use of manipulation in paediatric practice
Richey, R. H., Hughes, C., Craig, J. V., Shah, U. U., Ford, J. L., Barker, C. E., . . . Turner, M. A. (2017). A systematic review of the use of dosage form manipulation to obtain required doses to inform use of manipulation in paediatric practice. International Journal of Pharmaceutics, 518(1-2), 155-166. doi:10.1016/j.ijpharm.2016.12.032
Estimating the requirement for manipulation of medicines to provide accurate doses for children
Nunn, A., Richey, R., Shah, U., Barker, C., Craig, J., Peak, M., . . . Turner, M. (n.d.). Estimating the requirement for manipulation of medicines to provide accurate doses for children. Annual for Hospital Pharmacy, 1(1), 54. doi:10.14748/.v1i1.1882
Training in research competencies: a strategy for neonatology
Menon, G., Turner, M. A., Ogilvy-Stuart, A. L., & Greenough, A. (2017). Training in research competencies: a strategy for neonatology. ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION, 102(1), 51-+. doi:10.1136/archdischild-2015-309926
Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool
Bracken, L., Nunn, A., Kirkham, J. J., Peak, M., Arnott, J., Smyth, R. L., . . . Turner, M. (2017). Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool. PLoS ONE, 12(1). doi:10.1371/journal.pone.0169393
CEREBRAL BIOMARKERS IN EXTREMELY PRETERM INFANTS WITH A PATENT DUCTUS ARTERIOSUS
Kotidis, C., Turner, M., & Weindling, A. M. (2017). CEREBRAL BIOMARKERS IN EXTREMELY PRETERM INFANTS WITH A PATENT DUCTUS ARTERIOSUS. In ACTA PAEDIATRICA Vol. 106 (pp. 30). Retrieved from https://www.webofscience.com/
Correlation of Plasma and Salivary Cortisol in Extremely Premature Infants
M Ng, S., Drury, J., Upradrasta, S., Weindling, M., & A Turner, M. (n.d.). Correlation of Plasma and Salivary Cortisol in Extremely Premature Infants. Journal of Neonatal Biology, 06(03). doi:10.4172/2167-0897.1000260
Development of a Pediatric Adverse Events Terminology
Gipson, D. S., Kirkendall, E. S., Gumbs-Petty, B., Quinn, T., Steen, A., Hicks, A., . . . Hirschfeld, S. (2017). Development of a Pediatric Adverse Events Terminology. PEDIATRICS, 139(1). doi:10.1542/peds.2016-0985
Optimization of antimicrobial therapy for Gram-positive bacterial infections in children using a translational pharmacological approach
Ramos Martín, V. (2017). Optimization of antimicrobial therapy for Gram-positive bacterial infections in children using a translational pharmacological approach.
The future of pediatric research: European perspective
Molloy, E. J., Modi, N., Greenough, A., Lagercrantz, H., Bearer, C. F., & Turner, M. (2017). The future of pediatric research: European perspective. PEDIATRIC RESEARCH, 81(1), 138-139. doi:10.1038/pr.2016.225
The neonate
Turner, M. A. (2017). The neonate. In Obstetrics: By Ten Teachers, 20th Edition (pp. 297-329). doi:10.1201/9781315382401-16
Tools for the Individualized Therapy of Teicoplanin for Neonates and Children
Ramos-Martin, V., Neely, M. N., Padmore, K., Peak, M., Beresford, M. W., Turner, M. A., . . . Hope, W. W. (2017). Tools for the Individualized Therapy of Teicoplanin for Neonates and Children. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61(10). doi:10.1128/AAC.00707-17
2016
Propofol as an Adjunct for Neonatal Intubation: The Contribution of Clinical Pharmacology
Turner, M. A., & Davis, J. M. (2016). Propofol as an Adjunct for Neonatal Intubation: The Contribution of Clinical Pharmacology. JOURNAL OF PEDIATRICS, 179, 9-10. doi:10.1016/j.jpeds.2016.09.033
Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy.
Ramos-Martín, V., Neely, M. N., McGowan, P., Siner, S., Padmore, K., Peak, M., . . . Hope, W. W. (2016). Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy.. The Journal of antimicrobial chemotherapy, 71(11), 3168-3178. doi:10.1093/jac/dkw295
NEONATAL HAEMODYNAMICS: AN EMPIRICAL EVALUATION OF ONE CAUSAL PATHWAY
Kotidis, C., Weindling, M., & Turner, M. (2016). NEONATAL HAEMODYNAMICS: AN EMPIRICAL EVALUATION OF ONE CAUSAL PATHWAY. In EUROPEAN JOURNAL OF PEDIATRICS Vol. 175 (pp. 1702). Retrieved from https://www.webofscience.com/
NON-INFECTIVE INFLUENCES ON A CONTINUOUS PREDICTOR OF INFECTION (HeRO SCORE)
Lucas, C., Rodgers, B., Patel, A., Turner, M., Weindling, M., & Kotidis, C. (2016). NON-INFECTIVE INFLUENCES ON A CONTINUOUS PREDICTOR OF INFECTION (HeRO SCORE). In EUROPEAN JOURNAL OF PEDIATRICS Vol. 175 (pp. 1775-1776). Retrieved from https://www.webofscience.com/
The International Neonatal Consortium: collaborating to advance regulatory science for neonates
Turner, M. A., Davis, J. M., McCune, S., Bax, R., Portman, R. J., & Hudson, L. D. (2016). The International Neonatal Consortium: collaborating to advance regulatory science for neonates. PEDIATRIC RESEARCH, 80(4), 462-464. doi:10.1038/pr.2016.119
Research ethics committee decision-making in relation to an efficient neonatal trial.
Gale, C., Hyde, M. J., Modi, N., & WHEAT trial development group. (2016). Research ethics committee decision-making in relation to an efficient neonatal trial.. Archives of disease in childhood. Fetal and neonatal edition, 102(4), F291-F298. doi:10.1136/archdischild-2016-310935
Harmonisation in study design and outcomes in paediatric antibiotic clinical trials: a systematic review.
Folgori, L., Bielicki, J., Ruiz, B., Turner, M. A., Bradley, J. S., Benjamin, D. K., . . . Sharland, M. (2016). Harmonisation in study design and outcomes in paediatric antibiotic clinical trials: a systematic review.. The Lancet. Infectious diseases, 16(9), 178-189. doi:10.1016/s1473-3099(16)00069-4
PAEDIATRIC ADVERSE DRUG REACTIONS (ADRS): A COMPARISON OF A NEWLY DEVELOPED AVOIDABILITY TOOL TO EXISTING HALLAS ASSESSMENTS.
Bracken, L., Kirkham, J., Nunn, A., Pirmohamed, M., Peak, M., & Turner, M. (2016). PAEDIATRIC ADVERSE DRUG REACTIONS (ADRS): A COMPARISON OF A NEWLY DEVELOPED AVOIDABILITY TOOL TO EXISTING HALLAS ASSESSMENTS.. Poster session presented at the meeting of Unknown Conference.
Development and Evaluation of a Gentamicin Pharmacokinetic Model That Facilitates Opportunistic Gentamicin Therapeutic Drug Monitoring in Neonates and Infants
Germovsek, E., Kent, A., Metsvaht, T., Lutsar, I., Klein, N., Turner, M. A., . . . Standing, J. F. (2016). Development and Evaluation of a Gentamicin Pharmacokinetic Model That Facilitates Opportunistic Gentamicin Therapeutic Drug Monitoring in Neonates and Infants. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 60(8), 4869-4877. doi:10.1128/AAC.00577-16
Essential medicines containing ethanol elevate blood acetaldehyde concentrations in neonates
Pandya, H. C., Mulla, H., Hubbard, M., Cordell, R. L., Monks, P. S., Yakkundi, S., . . . Consortium, E. S. N. E. E. (2016). Essential medicines containing ethanol elevate blood acetaldehyde concentrations in neonates. European Journal of Pediatrics, 175, 841-847. doi:10.1007/s00431-016-2714-x
Product Substitution as a Way Forward in Avoiding Potentially Harmful Excipients in Neonates
Nellis, G., Metsvaht, T., Varendi, H., Lass, J., Duncan, J., Nunn, A. J., . . . Lutsar, I. (2016). Product Substitution as a Way Forward in Avoiding Potentially Harmful Excipients in Neonates. PEDIATRIC DRUGS, 18(3), 221-230. doi:10.1007/s40272-016-0173-5
Quantitative analysis of methyl and propyl parabens in neonatal DBS using LC-MS/MS
Yakkundi, S., Mulla, H., Pandya, H., Turner, M. A., & McElnay, J. (2016). Quantitative analysis of methyl and propyl parabens in neonatal DBS using LC-MS/MS. BIOANALYSIS, 8(11), 1173-1182. doi:10.4155/bio-2016-0029
Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates
Ramos-Martin, V., Johnson, A., Livermore, J., McEntee, L., Goodwin, J., Whalley, S., . . . Hope, W. W. (2016). Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates. Journal of Antimicrobial Chemotherapy, 71(4), 992-1002. doi:10.1093/jac/dkv451
Neonatal gram-negative infections, antibiotic susceptibility and clinical outcome: an observational study.
Kent, A., Kortsalioudaki, C., Monahan, I. M., Bielicki, J., Planche, T. D., Heath, P. T., . . . Neonatal Gram Negative MIC group. (2016). Neonatal gram-negative infections, antibiotic susceptibility and clinical outcome: an observational study.. Archives of disease in childhood. Fetal and neonatal edition, 101(6), F507-F512. doi:10.1136/archdischild-2015-309554
The minidex trial: Does very low dose dexamethasone improve lung function in preterm infants?
Yates, H. L., Johnson, K., & Turner, M. A. (2016). The minidex trial: Does very low dose dexamethasone improve lung function in preterm infants?. Infant, 12(2), 49-51.
Fit for Birth - the effect of weight changes in obese pregnant women on maternal and neonatal outcomes: a pilot prospective cohort study
Narayanan, R. P., Weeks, A. D., Quenby, S., Rycroft, D., Hart, A., Longworth, H., . . . Wilding, J. P. H. (2016). Fit for Birth - the effect of weight changes in obese pregnant women on maternal and neonatal outcomes: a pilot prospective cohort study. CLINICAL OBESITY, 6(1), 79-88. doi:10.1111/cob.12129
Safety study of Ciprofloxacin in newborn mice
Bourgeois, T., Delezoide, A. -L., Zhao, W., Guimiot, F., Adle-Biassette, H., Durand, E., . . . Matrot, B. (2016). Safety study of Ciprofloxacin in newborn mice. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 74, 161-169. doi:10.1016/j.yrtph.2015.11.002
Dose of prophylactic porcine surfactant and respiratory function within 12 hours of administration
Whitby, T., Martin, P., Leonard, G., Turner, M., & Yoxall, B. (2016). Dose of prophylactic porcine surfactant and respiratory function within 12 hours of administration. In EUROPEAN JOURNAL OF PEDIATRICS Vol. 175 (pp. 1760-1761). Retrieved from https://www.webofscience.com/
Dose of prophylactic porcine surfactant and survival without clinically defined bronchopulmonary dysplasia
Martin, P., Whitby, T., Leonard, G., Yoxall, B., & Turner, M. (2016). Dose of prophylactic porcine surfactant and survival without clinically defined bronchopulmonary dysplasia. In EUROPEAN JOURNAL OF PEDIATRICS Vol. 175 (pp. 1596). Retrieved from https://www.webofscience.com/
Future perspectives on neonatal drug development
Turner, M. (2016). Future perspectives on neonatal drug development. In EUROPEAN JOURNAL OF PEDIATRICS Vol. 175 (pp. 1416). Retrieved from https://www.webofscience.com/
NEONATAL CARDIOVASCULAR AND CEREBRAL FUNCTION AFTER ANTENATAL MATERNAL EXPOSURE TO MAGNESIUM SULFATE
Kotidis, C., Sharp, A., Alfirevic, Z., Weindling, M., & Turner, M. (2016). NEONATAL CARDIOVASCULAR AND CEREBRAL FUNCTION AFTER ANTENATAL MATERNAL EXPOSURE TO MAGNESIUM SULFATE. Poster session presented at the meeting of Unknown Conference. Retrieved from https://www.webofscience.com/
Neonatal randomised point-of-care trials are feasible and acceptable in the UK: results from two national surveys
Gale, C., & Modi, N. (2016). Neonatal randomised point-of-care trials are feasible and acceptable in the UK: results from two national surveys. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 101(1), 86. Retrieved from https://www.webofscience.com/
PHARMACOKINETIC STUDIES IN NEONATES: IS AN OPPORTUNISTIC SAMPLING STRATEGY SUFFICIENT FOR POPULATION PHARMACOKINETIC MODELLING AND DOSE PREDICTION?
Leroux, S., Turner, M. A., Guellec, C. B. -L., Hill, H., Anker, J. N. V. D., Kearns, G. L., . . . Zhao, W. (2016). PHARMACOKINETIC STUDIES IN NEONATES: IS AN OPPORTUNISTIC SAMPLING STRATEGY SUFFICIENT FOR POPULATION PHARMACOKINETIC MODELLING AND DOSE PREDICTION?. Archives of Disease in Childhood, 101(1), e1.11-e1. doi:10.1136/archdischild-2015-310148.19
RECOMBINANT HUMAN IGF-1/IGFBP-3 FOR THE PREVENTION OF COMORBIDITIES OF PREMATURITY: RESULTS OF A PHASE 2 RANDOMISED CONTROLLED TRIAL
Ley, D., Hallberg, B., Hansen-Pupp, I., Ramenghi, L., Turner, M., Dani, C., . . . Hellstrom, A. (2016). RECOMBINANT HUMAN IGF-1/IGFBP-3 FOR THE PREVENTION OF COMORBIDITIES OF PREMATURITY: RESULTS OF A PHASE 2 RANDOMISED CONTROLLED TRIAL. In EUROPEAN JOURNAL OF PEDIATRICS Vol. 175 (pp. 1508-1509). Retrieved from https://www.webofscience.com/
SPONTANEOUS ADVERSE DRUG REACTION REPORTS FOR NEONATES AND INFANTS IN THE UK 2001–2010
Hawcutt, D., Maqsood, H., Gomberg, S., Riordan, A., & Turner, M. (2016). SPONTANEOUS ADVERSE DRUG REACTION REPORTS FOR NEONATES AND INFANTS IN THE UK 2001–2010. Archives of Disease in Childhood, 101(1), e1.43-e1. doi:10.1136/archdischild-2015-310148.48
SPONTANEOUS ADVERSE DRUG REACTION REPORTS FOR TRANSPLACENTAL AND TRANSMAMMARY ROUTES IN THOSE ≤1 YEAR IN THE UK 2001–2010
Russell, N. -J., Turner, M., & Hawcutt, D. (2016). SPONTANEOUS ADVERSE DRUG REACTION REPORTS FOR TRANSPLACENTAL AND TRANSMAMMARY ROUTES IN THOSE ≤1 YEAR IN THE UK 2001–2010. Archives of Disease in Childhood, 101(1), e1.21-e1. doi:10.1136/archdischild-2015-310148.28
Spontaneous adverse drug reaction reports for neonates and infants in the UK 2001-2010: content and utility analysis
Hawcutt, D. B., Russell, N. J., Maqsood, H., Kouranloo, K., Gomberg, S., Waitt, C., . . . Turner, M. A. (2016). Spontaneous adverse drug reaction reports for neonates and infants in the UK 2001-2010: content and utility analysis. British journal of clinical pharmacology, 82(06), 1601-1612. doi:10.1111/bcp.13067
VALIDATION OF PDA SEVERITY SCORE IN PREDICTING CHRONIC LUNG DISEASE (CLD) IN EXTREMELY PRETERM INFANTS WITH PATENT DUCTUS ARTERIOSUS
Kotidis, C., Weindling, M., Subhedar, N., & Turner, M. (2016). VALIDATION OF PDA SEVERITY SCORE IN PREDICTING CHRONIC LUNG DISEASE (CLD) IN EXTREMELY PRETERM INFANTS WITH PATENT DUCTUS ARTERIOSUS. In EUROPEAN JOURNAL OF PEDIATRICS Vol. 175 (pp. 1557-1558). Retrieved from https://www.webofscience.com/
What makes a network successful?
Turner, M. (2016). What makes a network successful?. In EUROPEAN JOURNAL OF PEDIATRICS Vol. 175 (pp. 1413). Retrieved from https://www.webofscience.com/
2015
Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design
Leroux, S., Turner, M. A., Barin-Le Guellec, C., Hill, H., van den Anker, J. N., Kearns, G. L., . . . Zhao, W. (2015). Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design. CLINICAL PHARMACOKINETICS, 54(12), 1273-1285. doi:10.1007/s40262-015-0291-1
Why are Excipients Important to Neonates?
Turner, M. A., & Shah, U. (2015). Why are Excipients Important to Neonates?. CURRENT PHARMACEUTICAL DESIGN, 21(39), 5680-5687. doi:10.2174/1381612821666150901110341
Do maternal factors influence neonatal thyroid status in the extreme premature infant?
Ng, S. M., Watson, G., Turner, M. A., Newland, P., & Weindling, A. M. (2015). Do maternal factors influence neonatal thyroid status in the extreme premature infant?. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 28(15), 1846-1849. doi:10.3109/14767058.2014.970158
Global Collaboration to Develop New and Existing Drugs for Neonates
Davis, J. M., & Turner, M. A. (2015). Global Collaboration to Develop New and Existing Drugs for Neonates. JAMA PEDIATRICS, 169(10), 887-888. doi:10.1001/jamapediatrics.2015.1640
Magnetic Resonance Biomarkers in Neonatal Encephalopathy (MARBLE): a prospective multicountry study
Lally, P. J., Pauliah, S., Montaldo, P., Chaban, B., Oliveira, V., Bainbridge, A., . . . Thayyil, S. (2015). Magnetic Resonance Biomarkers in Neonatal Encephalopathy (MARBLE): a prospective multicountry study. BMJ OPEN, 5(9). doi:10.1136/bmjopen-2015-008912
Pediatric Microdose and Microtracer Studies Using <SUP>14</SUP>C in Europe
Turner, M. A., Mooij, M. G., Vaes, W. H. J., Windhorst, A. D., Hendrikse, N. H., Knibbe, C. A. J., . . . de Wildt, S. N. (2015). Pediatric Microdose and Microtracer Studies Using <SUP>14</SUP>C in Europe. CLINICAL PHARMACOLOGY & THERAPEUTICS, 98(3), 234-237. doi:10.1002/cpt.163
Seeing and Holding Baby: Systematic Review of Clinical Management and Parental Outcomes After Stillbirth
Kingdon, C., Givens, J. L., O'Donnell, E., & Turner, M. (2015). Seeing and Holding Baby: Systematic Review of Clinical Management and Parental Outcomes After Stillbirth. BIRTH-ISSUES IN PERINATAL CARE, 42(3), 206-218. doi:10.1111/birt.12176
The Role of Healthcare Professionals in Encouraging Parents to See and Hold Their Stillborn Baby: A Meta-Synthesis of Qualitative Studies
Kingdon, C., O'Donnell, E., Givens, J., & Turner, M. (2015). The Role of Healthcare Professionals in Encouraging Parents to See and Hold Their Stillborn Baby: A Meta-Synthesis of Qualitative Studies. PLOS ONE, 10(7). doi:10.1371/journal.pone.0130059
Neonatal medicines research: challenges and opportunities
Samardzic, J., Turner, M. A., Bax, R., & Allegaert, K. (2015). Neonatal medicines research: challenges and opportunities. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 11(7), 1041-1052. doi:10.1517/17425255.2015.1046433
Investigation of Neonatal Encephalopathy: The Oft-Lost Placental "Black Box''
Clarke, P., Muniraman, H., Gardner, D., Venkatesh, V., Curley, A., Victor, S., & Turner, M. A. (2015). Investigation of Neonatal Encephalopathy: The Oft-Lost Placental "Black Box''. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 18(4), 343-344. doi:10.2350/15-02-1611-LET.1
Potentially harmful excipients in neonatal medicines: a pan-European observational study
Nellis, G., Metsvaht, T., Varendi, H., Toompere, K., Lass, J., Mesek, I., . . . Lutsar, I. (2015). Potentially harmful excipients in neonatal medicines: a pan-European observational study. Archives of Disease in Childhood, 100(7), 694-699. doi:10.1136/archdischild-2014-307793
Observational infant exploratory [C-14]-paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis
Garner, R. C., Park, K. B., French, N. S., Earnshaw, C., Schipani, A., Selby, A. M., . . . Turner, M. A. (2015). Observational infant exploratory [C-14]-paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis. British Journal Of Clinical Pharmacology, 80(1), 157-167. doi:10.1111/bcp.12597
Cardiovascular support during neonatal intensive care
Brunton, A., Turner, M. A., & Paize, F. (2015). Cardiovascular support during neonatal intensive care. Paediatrics and Child Health, 25(6), 249-255. doi:10.1016/j.paed.2015.02.004
Concentrated parenteral nutrition solutions and central venous catheter complications in preterm infants
Whitby, T., McGowan, P., Turner, M. A., & Morgan, C. (2015). Concentrated parenteral nutrition solutions and central venous catheter complications in preterm infants. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 100(3), F250-F252. doi:10.1136/archdischild-2014-306409
High variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: implications for research and dissemination
Metsvaht, T., Nellis, G., Varendi, H., Nunn, A. J., Graham, S., Rieutord, A., . . . Lutsar, I. (2015). High variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: implications for research and dissemination. BMC Pediatrics, 15. doi:10.1186/s12887-015-0359-y
G25 Communicating with parents following a suspected adverse drug reaction in a child: who says what and when?
Arnott, J., Nunn, A. J., Mannix, H., Peak, M., Pirmohamed, M., Smyth, R. L., . . . Young, B. (2015). G25 Communicating with parents following a suspected adverse drug reaction in a child: who says what and when?. Archives of Disease in Childhood, 100(Suppl 3), A10.3-A11. doi:10.1136/archdischild-2015-308599.25
G26 Parents’ experiences of administering and manipulating medicines for children with long term chronic conditions
Arnott, J., Richey, R., Peak, M., Nunn, A. J., & Turner, M. A. (2015). G26 Parents’ experiences of administering and manipulating medicines for children with long term chronic conditions. Archives of Disease in Childhood, 100(Suppl 3), A11.1-A11. doi:10.1136/archdischild-2015-308599.26
Successful private-public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines
Ruggieri, L., Giannuzzi, V., Baiardi, P., Bonifazi, F., Davies, E. H., Giaquinto, C., . . . Ceci, A. (2015). Successful private-public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines. EUROPEAN JOURNAL OF PEDIATRICS, 174(4), 481-491. doi:10.1007/s00431-014-2398-z
Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conduct
Turner, M. A. (2015). Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conduct. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 79(3), 370-378. doi:10.1111/bcp.12467
An observational study of blood concentrations and kinetics of methyl- and propyl-parabens in neonates.
Mulla, H., Yakkundi, S., McElnay, J., Lutsar, I., Metsvaht, T., Varendi, H., . . . Turner, M. (2015). An observational study of blood concentrations and kinetics of methyl- and propyl-parabens in neonates.. Pharmaceutical Research, 32(3), 1084-1093. doi:10.1007/s11095-014-1520-2
Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates: Report of the US Food and Drug Administration First Annual Neonatal Scientific Workshop, October 28-29, 2014
Offringa, M., Davis, J. M., Turner, M. A., Ward, R., Bax, R., Maldonado, S., . . . Nelson, R. M. (2015). Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates: Report of the US Food and Drug Administration First Annual Neonatal Scientific Workshop, October 28-29, 2014. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 49(5), 623-631. doi:10.1177/2168479015597730
European survey evaluating the use of azithromycin in neonates
Pansieri, C., Pandolfini, C., Elie, V., Turner, M., Kotecha, S., Bonati, M., & Jacqz-Aigrain, E. (2015). European survey evaluating the use of azithromycin in neonates. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 29, 43. Retrieved from https://www.webofscience.com/
Neonatal Formulations and Additives
Allegaert, K., Turner, M. A., & van den Anker, J. N. (2015). Neonatal Formulations and Additives. NEONATAL PHARMACOLOGY AND NUTRITION UPDATE, 18, 41-57. doi:10.1159/000365021
POPULATION PHARMACOKINETICS OF CIPROFLOXACIN AND DOSING RECOMMENDATION IN NEONATES AND INFANTS LESS THAN 3 MONTHS OF AGE.
Barin-Le Guellec, C., Zhao, W., Kassai, B., Turner, M. A., & Jacqz-Aigrain, E. (2015). POPULATION PHARMACOKINETICS OF CIPROFLOXACIN AND DOSING RECOMMENDATION IN NEONATES AND INFANTS LESS THAN 3 MONTHS OF AGE.. In CLINICAL PHARMACOLOGY & THERAPEUTICS Vol. 97 (pp. S77). Retrieved from https://www.webofscience.com/
Pharmacovigilance in Neonatal Intensive Care
Turner, M. A., & Hill, H. (2015). Pharmacovigilance in Neonatal Intensive Care. NEONATAL PHARMACOLOGY AND NUTRITION UPDATE, 18, 28-40. doi:10.1159/000364991
2014
The incidence and implications of cerebral palsy following potentially avoidable obstetric complications: a preliminary burden of disease study
Leigh, S., Granby, P., Turner, M., Wieteska, S., Haycox, A., & Collins, B. (2014). The incidence and implications of cerebral palsy following potentially avoidable obstetric complications: a preliminary burden of disease study. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 121(13), 1720-1728. doi:10.1111/1471-0528.12897
Adverse drug reactions in neonates: could we be documenting more?
Hawcutt, D. B., O'Connor, O., & Turner, M. A. (2014). Adverse drug reactions in neonates: could we be documenting more?. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 7(6), 807-820. doi:10.1586/17512433.2014.956090
Population Pharmacokinetics of Teicoplanin in Children
Ramos-Martin, V., Paulus, S., Siner, S., Scott, E., Padmore, K., Newland, P., . . . Hope, W. W. (2014). Population Pharmacokinetics of Teicoplanin in Children. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 58(11), 6920-6927. doi:10.1128/AAC.03685-14
Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age
Zhao, W., Hill, H., Le Guellec, C., Neal, T., Mahoney, S., Paulus, S., . . . Jacqz-Aigrain, E. (2014). Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age. Antimicrobial Agents and Chemotherapy, 58(11), 6572-6580. doi:10.1128/AAC.03568-14
O-098 Potentially Harmful Excipients In Medicines Prescribed In Neonatal Intensive Care Units (nicu) – Product Substitution As A Way Forward
Nellis, G., Lutsar, I., Varendi, H., Lass, J., Turner, M. A., & Metsvaht, T. (2014). O-098 Potentially Harmful Excipients In Medicines Prescribed In Neonatal Intensive Care Units (nicu) – Product Substitution As A Way Forward. Archives of Disease in Childhood, 99(Suppl 2), A61.3-A62. doi:10.1136/archdischild-2014-307384.165
O-106 Populationpharmacokinetic Model Of The Antimicrobial Excipient Methyl Paraben Administered In Routine Clinical Practice To Neonates: Abstract O-106 Table 1
Mulla, H., Yakkundi, S., McElnay, J., Varendi, H., Metsvaht, T., Nellis, G., . . . Turner, M. A. (2014). O-106 Populationpharmacokinetic Model Of The Antimicrobial Excipient Methyl Paraben Administered In Routine Clinical Practice To Neonates: Abstract O-106 Table 1. Archives of Disease in Childhood, 99(Suppl 2), A65.2-A66. doi:10.1136/archdischild-2014-307384.173
O-137 Screening And Recruitment To Clinical Studies On A Regional Neonatal Unit: A Comparison Of Three Studies With Contrasting Characteristics: Abstract O-137 Table 1
McGowan, P., Windrow, J., Harvey, K., Howell, B., & Turner, M. A. (2014). O-137 Screening And Recruitment To Clinical Studies On A Regional Neonatal Unit: A Comparison Of Three Studies With Contrasting Characteristics: Abstract O-137 Table 1. Archives of Disease in Childhood, 99(Suppl 2), A77.1-A77. doi:10.1136/archdischild-2014-307384.204
PO-0925 Children And Young People’s Experiences Of Adverse Drug Reactions And Pharmacovigilance In The Uk
Arnott, J., Hesselgreave, H., Nunn, A. J., Peak, M., Pirmohamed, M., Smyth, R. L., . . . Young, B. (2014). PO-0925 Children And Young People’s Experiences Of Adverse Drug Reactions And Pharmacovigilance In The Uk. Archives of Disease in Childhood, 99(Suppl 2), A552.2-A552. doi:10.1136/archdischild-2014-307384.1546
PO-0926 Are Group Assessments Superior To Individual Avoidability Assessments? A Test Of The Liverpool Adverse Drug Reaction Avoidability Assessment Tool
Bracken, L. E., Duncan, J. C., Peak, M., Arnott, J., Kirkham, J. J., Nunn, A. J., . . . Turner, M. A. (2014). PO-0926 Are Group Assessments Superior To Individual Avoidability Assessments? A Test Of The Liverpool Adverse Drug Reaction Avoidability Assessment Tool. Archives of Disease in Childhood, 99(Suppl 2), A552.3-A553. doi:10.1136/archdischild-2014-307384.1547
PO-0930 Enpr-ema, A Platform For Disseminating Good Practices About Paediatric Medicines Research Across Europe And With International Partners
Pelle, B., Eichler, I., & Turner, M. (2014). PO-0930 Enpr-ema, A Platform For Disseminating Good Practices About Paediatric Medicines Research Across Europe And With International Partners. Archives of Disease in Childhood, 99(Suppl 2), A554.2-A554. doi:10.1136/archdischild-2014-307384.1551
PO-0934 Comparative Paediatric Acetaminophen Pharmacokinetics Between A Microdose And A Therapeutic Dose Using Accelerator Mass Spectrometry Bioanalysis: Abstract PO-0934 Table 1
Turner, M. A., Park, B. K., French, N. S., Earnshaw, C., Schipani, A., Selby, A. M., . . . Garner, R. C. (2014). PO-0934 Comparative Paediatric Acetaminophen Pharmacokinetics Between A Microdose And A Therapeutic Dose Using Accelerator Mass Spectrometry Bioanalysis: Abstract PO-0934 Table 1. Archives of Disease in Childhood, 99(Suppl 2), A556.2-A556. doi:10.1136/archdischild-2014-307384.1555
PS-052 Setting Preterm Birth Research Priorities With Multiple Professions And Service Users In The Uk
Uhm, S., Alderdice, F., Brady, I., Chambers, B., Chivers, Z., Crowe, S., . . . Oliver, S. (2014). PS-052 Setting Preterm Birth Research Priorities With Multiple Professions And Service Users In The Uk. Archives of Disease in Childhood, 99(Suppl 2), A130.3-A131. doi:10.1136/archdischild-2014-307384.349
PS-128 The Ethics Of Microdosing Studies In Children: The Experience Of The Era-net Priomedchild Project Pamper
Crawley, F., Vaes, W. H. J., Selby, A., Varendi, H., Turner, M., Park, B. K., . . . Garner, R. C. (2014). PS-128 The Ethics Of Microdosing Studies In Children: The Experience Of The Era-net Priomedchild Project Pamper. Archives of Disease in Childhood, 99(Suppl 2), A156.3-A157. doi:10.1136/archdischild-2014-307384.423
PS-266 Hyperalimentation And Blood Glucose Control In Very Preterm Infants: The Randomised Controlled Scamp Nutrition Study: Abstract PS-266 Table 1
Morgan, C., Burgess, L., Grosdenier, M., McGowan, P., & Turner, M. A. (2014). PS-266 Hyperalimentation And Blood Glucose Control In Very Preterm Infants: The Randomised Controlled Scamp Nutrition Study: Abstract PS-266 Table 1. Archives of Disease in Childhood, 99(Suppl 2), A208.2-A208. doi:10.1136/archdischild-2014-307384.566
Induction of labour in pre-eclamptic women: a randomised trial comparing the Foley balloon catheter with oral misoprostol
Bracken, H., Mundle, S., Faragher, B., Easterling, T., Haycox, A., Turner, M., . . . Weeks, A. (2014). Induction of labour in pre-eclamptic women: a randomised trial comparing the Foley balloon catheter with oral misoprostol. BMC PREGNANCY AND CHILDBIRTH, 14. doi:10.1186/1471-2393-14-308
Neonatal invasive fungal infection in England 2004-2010
Oeser, C., Vergnano, S., Naidoo, R., Anthony, M., Chang, J., Chow, P., . . . Heath, P. T. (2014). Neonatal invasive fungal infection in England 2004-2010. CLINICAL MICROBIOLOGY AND INFECTION, 20(9), 936-941. doi:10.1111/1469-0691.12578
DEVELOPMENT OF AN ADVERSE DRUG REACTION AVOIDABILITY ASSESSMENT TOOL
Bracken, L., Kirkham, J., Nunn, A., Pirmohamed, M., & Turner, M. (2014). DEVELOPMENT OF AN ADVERSE DRUG REACTION AVOIDABILITY ASSESSMENT TOOL. Archives of Disease in Childhood, 99(8), e3. doi:10.1136/archdischild-2014-306798.34
Comparison of two alternative study designs in assessment of medicines utilisation in neonates
Nellis, G., Lutsar, I., Varendi, H., Toompere, K., Turner, M. A., Duncan, J., & Metsvaht, T. (2014). Comparison of two alternative study designs in assessment of medicines utilisation in neonates. BMC MEDICAL RESEARCH METHODOLOGY, 14. doi:10.1186/1471-2288-14-89
Toxic excipients in medications for neonates in Brazil.
Souza, A., Santos, D., Fonseca, S., Medeiros, M., Batista, L., Turner, M., & Coelho, H. (2014). Toxic excipients in medications for neonates in Brazil.. European Journal of Pediatrics, 173(7), 935-945. doi:10.1007/s00431-014-2272-z
Paediatric drug development: The impact of evolving regulations
Turner, M. A., Catapano, M., Hirschfeld, S., & Giaquinto, C. (2014). Paediatric drug development: The impact of evolving regulations. ADVANCED DRUG DELIVERY REVIEWS, 73, 2-13. doi:10.1016/j.addr.2014.02.003
Risk assessment of neonatal excipient exposure: Lessons from food safety and other areas
Turner, M. A., Duncan, J. C., Shah, U., Metsvaht, T., Varendi, H., Nellis, G., . . . Nunn, A. J. (2014). Risk assessment of neonatal excipient exposure: Lessons from food safety and other areas. ADVANCED DRUG DELIVERY REVIEWS, 73, 89-101. doi:10.1016/j.addr.2013.11.003
Is Dopamine an Iatrogenic Disruptor of Thyroid and Cortisol Function in the Extremely Premature Infant?
Ng, S. M., Watson, G., Turner, M. A., Newland, P., & Weindling, A. M. (2014). Is Dopamine an Iatrogenic Disruptor of Thyroid and Cortisol Function in the Extremely Premature Infant?. Advances in Endocrinology, 2014, 1-4. doi:10.1155/2014/973184
4.1 Hyperalimentation and blood glucose control in very preterm infants: a randomised controlled parenteral nutrition study: Abstract 4.1 Table 1
Morgan, C., Burgess, L., Grosdenier, M., Green, J., McGowan, P., & Turner, M. A. (2014). 4.1 Hyperalimentation and blood glucose control in very preterm infants: a randomised controlled parenteral nutrition study: Abstract 4.1 Table 1. Archives of Disease in Childhood - Fetal and Neonatal Edition, 99(Suppl 1), A2.3-A3. doi:10.1136/archdischild-2014-306576.6
8.8 Neonatal Encephalopathy in the Cooling Therapy era – Preliminary Cerebral Magnetic Resonance results from the Marble Consortium
Pauliah, S. S., Lally, P. J., Bainbridge, A., Price, D. L., Addison, S., Cowan, F. M., . . . Thayyil, S. (2014). 8.8 Neonatal Encephalopathy in the Cooling Therapy era – Preliminary Cerebral Magnetic Resonance results from the Marble Consortium. Archives of Disease in Childhood - Fetal and Neonatal Edition, 99(Suppl 1), A13.2-A14. doi:10.1136/archdischild-2014-306576.37
PC.26 Feasibility of Magnetic Resonance Spectroscopy in Examining Thalamic Metabolite Concentrations in a Multi-Centre Study of Neonatal Encephalopathy
Lally, P. J., Price, D. L., Bainbridge, A., Pauliah, S. S., Satodia, P., Wayte, S. C., . . . Thayyil, S. (2014). PC.26 Feasibility of Magnetic Resonance Spectroscopy in Examining Thalamic Metabolite Concentrations in a Multi-Centre Study of Neonatal Encephalopathy. Archives of Disease in Childhood - Fetal and Neonatal Edition, 99(Suppl 1), A44.3-A45. doi:10.1136/archdischild-2014-306576.128
PC.45 Quantification of N-Acetylaspartate Concentration in the Neonatal Brain: Initial Results from the Multi-Centre Marble Study
Lally, P. J., Pauliah, S. S., Price, D. L., Bainbridge, A., Addison, S., Soe, A., . . . Thayyil, S. (2014). PC.45 Quantification of N-Acetylaspartate Concentration in the Neonatal Brain: Initial Results from the Multi-Centre Marble Study. Archives of Disease in Childhood - Fetal and Neonatal Edition, 99(Suppl 1), A51.2-A51. doi:10.1136/archdischild-2014-306576.146
PC.53 Concentrated parenteral nutrition solutions and central venous catheter complications in preterm infants: Abstract PC.53 Table 1
Whitby, T., Morgan, C., McGowan, P., & Turner, M. (2014). PC.53 Concentrated parenteral nutrition solutions and central venous catheter complications in preterm infants: Abstract PC.53 Table 1. Archives of Disease in Childhood - Fetal and Neonatal Edition, 99(Suppl 1), A54.2-A54. doi:10.1136/archdischild-2014-306576.154
PPO.23 Top 15 research priorities for preterm birth with clinicians and service users’ involvement – outcomes from a James Lind Alliance priority setting partnership
Uhm, S., Alderdice, F., Chambers, B., Gyte, G., Gale, C., Duley, L., . . . Oliver, S. (2014). PPO.23 Top 15 research priorities for preterm birth with clinicians and service users’ involvement – outcomes from a James Lind Alliance priority setting partnership. Archives of Disease in Childhood - Fetal and Neonatal Edition, 99(Suppl 1), A158.1-A158. doi:10.1136/archdischild-2014-306576.463
ABSTRACT 131
Byrne, L., Selby, A., Siner, S., Scott, E., Garner, R. C., Earnshaw, C., . . . Turner, M. (2014). ABSTRACT 131. Pediatric Critical Care Medicine, 15, 34. doi:10.1097/01.pcc.0000448857.55739.f9
ABSTRACT 707
Selby, A., Byrne, L., Siner, S., Scott, E., Garner, R. C., Earnshaw, C., . . . Turner, M. (2014). ABSTRACT 707. Pediatric Critical Care Medicine, 15, 160. doi:10.1097/01.pcc.0000449433.53814.06
Antibiotics for early‐onset neonatal infection: a summary of the <scp>NICE</scp> guideline 2012
Mugglestone, M. A., Murphy, M. S., Visintin, C., Howe, D. T., & Turner, M. A. (2014). Antibiotics for early‐onset neonatal infection: a summary of the <scp>NICE</scp> guideline 2012. The Obstetrician & Gynaecologist, 16(2), 87-92. doi:10.1111/tog.12085
G455 Antenatal advance care planning: 3 years experience from a single centre
Holt, S., Lim, J., Jones, C., Bricker, L., Turner, M., Agarwal, U., . . . Brook, L. (2014). G455 Antenatal advance care planning: 3 years experience from a single centre. Archives of Disease in Childhood, 99(Suppl 1), A189. doi:10.1136/archdischild-2014-306237.437
Aminoglycoside toxicity in neonates: something to worry about?
Kent, A., Turner, M. A., Sharland, M., & Heath, P. T. (2014). Aminoglycoside toxicity in neonates: something to worry about?. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 12(3), 319-331. doi:10.1586/14787210.2014.878648
<i>Ureaplasma</i>, bronchopulmonary dysplasia, and azithromycin in European neonatal intensive care units: a survey
Pansieri, C., Pandolfini, C., Elie, V., Turner, M. A., Kotecha, S., Jacqz-Aigrain, E., & Bonati, M. (2014). <i>Ureaplasma</i>, bronchopulmonary dysplasia, and azithromycin in European neonatal intensive care units: a survey. SCIENTIFIC REPORTS, 4. doi:10.1038/srep04076
Postnatal head growth in preterm infants: a randomized controlled parenteral nutrition study
Morgan, C., McGowan, P., Herwitker, S., Hart, A. E., & Turner, M. (2014). Postnatal head growth in preterm infants: a randomized controlled parenteral nutrition study. Pediatrics, 133(1), e120-e128. doi:10.1542/peds.2013-2207
ADRIC: Adverse Drug Reactions In Children – a programme of research using mixed methods
Smyth, R. L., Peak, M., Turner, M. A., Nunn, A. J., Williamson, P. R., Young, B., . . . Pirmohamed, M. (2014). ADRIC: Adverse Drug Reactions In Children – a programme of research using mixed methods.
Does extending luteal support with progesterone beyond positive pregnancy test following IVF treatment improve pregnancy outcome?
Russell, R. T., Gazvani, M., Kingsland, C. R., Alfirevic, Z., Turner, M., Sajjad, Y., . . . Townend, J. (2014). Does extending luteal support with progesterone beyond positive pregnancy test following IVF treatment improve pregnancy outcome?. In HUMAN REPRODUCTION Vol. 29 (pp. 110). Retrieved from https://www.webofscience.com/
Effect of thyroxine on brain microstructure in extremely premature babies: magnetic resonance imaging findings in the TIPIT study.
Ng, S. M., Turner, M., Gamble, C., Didi, M., Victor, S., Atkinson, J., . . . Weindling, A. M. (2014). Effect of thyroxine on brain microstructure in extremely premature babies: magnetic resonance imaging findings in the TIPIT study.. Pediatric Radiology, 44, 987-996. doi:10.1007/s00247-014-2911-6
European network on evaluation of anti-infective agents for the treatment of preterm and term neonates
Legrand, F., Matrot, B., Choonara, I., Kassai, B., Manzoni, P., Turner, M., . . . Jacqz-Aigrain, E. (2014). European network on evaluation of anti-infective agents for the treatment of preterm and term neonates. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 28, 69. Retrieved from https://www.webofscience.com/
Global resarch in paediatrics: training program in paediatric clinical pharmacology
Jacqz-Aigrain, E., Turner, M., Van den Anker, J., Rossi, P., & Hoppu, K. (2014). Global resarch in paediatrics: training program in paediatric clinical pharmacology. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 28, 93. Retrieved from https://www.webofscience.com/
Tinn2: treat infections in neonates 2, european survey evaluating the use of azithromycin in neonates
Pansieri, C., Pandolfini, C., Elie, V., Turner, M., Kotecha, S., Bonati, M., & Jacqz-Aigrain, E. (2014). Tinn2: treat infections in neonates 2, european survey evaluating the use of azithromycin in neonates. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 28, 98. Retrieved from https://www.webofscience.com/
Uterine natural killer (uNK) cells and recurrent miscarriage : a pilot randomised controlled trial of prednisolone in women with high uNK cells and recurrent miscarriage
Tang, A. -W. (2014). Uterine natural killer (uNK) cells and recurrent miscarriage : a pilot randomised controlled trial of prednisolone in women with high uNK cells and recurrent miscarriage.
2013
Clinical trials in neonatal sepsis
Oeser, C., Lutsar, I., Metsvaht, T., Turner, M. A., Heath, P. T., & Sharland, M. (2013). Clinical trials in neonatal sepsis. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 68(12), 2733-2745. doi:10.1093/jac/dkt297
The application of mechanical aerosol delivery systems in an in vitro model of mechanically ventilated neonates.
Ehtezazi, T., & Turner, M. A. (2013). The application of mechanical aerosol delivery systems in an in vitro model of mechanically ventilated neonates.. Recent patents on drug delivery & formulation, 7(3), 174-183. doi:10.2174/18722113113076660012
European Study of Neonatal Exposure to Excipients: An update
Turner, M. A., Duncan, J., Shah, U., Metsvaht, T., Varendi, H., Nellis, G., . . . Nunn, A. J. (2013). European Study of Neonatal Exposure to Excipients: An update. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 457(1), 357-358. doi:10.1016/j.ijpharm.2013.08.078
MODRIC - Manipulation of drugs in children
Richey, R. H., Craig, J. V., Shah, U. U., Nunn, A. J., Turner, M. A., Barker, C. E., . . . Peak, M. (2013). MODRIC - Manipulation of drugs in children. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 457(1), 339-341. doi:10.1016/j.ijpharm.2013.08.061
Adverse drug reactions and off-label and unlicensed medicines in children: a nested case-control study of inpatients in a pediatric hospital
Bellis, J. R., Kirkham, J. J., Thiesen, S., Conroy, E. J., Bracken, L. E., Mannix, H. L., . . . Pirmohamed, M. (2013). Adverse drug reactions and off-label and unlicensed medicines in children: a nested case-control study of inpatients in a pediatric hospital. BMC MEDICINE, 11. doi:10.1186/1741-7015-11-238
Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions
Thiesen, S., Conroy, E. J., Bellis, J. R., Bracken, L. E., Mannix, H. L., Bird, K. A., . . . Smyth, R. L. (2013). Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions. BMC MEDICINE, 11. doi:10.1186/1741-7015-11-237
An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks' gestation: results of the TIPIT trial
Ng, S. M., Turner, M. A., Gamble, C., Didi, M., Victor, S., Manning, D., . . . Weindling, A. M. (2013). An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks' gestation: results of the TIPIT trial. TRIALS, 14. doi:10.1186/1745-6215-14-211
A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant
Tang, A. -W., Alfirevic, Z., Turner, M. A., Drury, J. A., Small, R., & Quenby, S. (2013). A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant. HUMAN REPRODUCTION, 28(7), 1743-1752. doi:10.1093/humrep/det117
Randomized controlled trials of antibiotics for neonatal infections: a systematic review
Kaguelidou, F., Turner, M. A., Choonara, I., van Anker, J., Manzoni, P., Alberti, C., . . . Jacqz-Aigrain, E. (2013). Randomized controlled trials of antibiotics for neonatal infections: a systematic review. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 76(1), 21-29. doi:10.1111/bcp.12113
G169 Preventing Early Postnatal Head Growth Failure in Very Preterm Infants: The Randomised Controlled SCAMP Nutrition Study
Morgan, C., McGowan, P., Herwitker, S., Hart, A., & Turner, M. (2013). G169 Preventing Early Postnatal Head Growth Failure in Very Preterm Infants: The Randomised Controlled SCAMP Nutrition Study. Archives of Disease in Childhood, 98(Suppl 1), A77-A78. doi:10.1136/archdischild-2013-304107.181
Manipulation of medicines to deliver a required dose: development of a good practice guideline
Richey, R., Barker, C., Shah, U., Peak, M., Nunn, A., J, C., . . . M, T. (2013). Manipulation of medicines to deliver a required dose: development of a good practice guideline. Archives of Disease in Childhood, 98(6), e1. doi:10.1136/archdischild-2013-303935a.22
Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence
Richey, R. H., Shah, U. U., Peak, M., Craig, J. V., Ford, J. L., Barker, C. E., . . . Turner, M. A. (2013). Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence. BMC PEDIATRICS, 13. doi:10.1186/1471-2431-13-81
GC-MS analysis of ethanol and other volatile compounds in micro-volume blood samples-quantifying neonatal exposure
Cordell, R. L., Pandya, H., Hubbard, M., Turner, M. A., & Monks, P. S. (2013). GC-MS analysis of ethanol and other volatile compounds in micro-volume blood samples-quantifying neonatal exposure. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 405(12), 4139-4147. doi:10.1007/s00216-013-6809-1
A novel method of collection of saliva for estimation of steroid levels in extremely premature infants
Ng, S. M., Drury, J. A., Turner, M. A., Didi, M., Victor, S., Newland, P., & Weindling, A. M. (2013). A novel method of collection of saliva for estimation of steroid levels in extremely premature infants. ACTA PAEDIATRICA, 102(4), 356-359. doi:10.1111/apa.12146
A rapid, reliable method for uNK cell density estimation
Drury, J. A., Tang, A. -W., Turner, M. A., & Quenby, S. (2013). A rapid, reliable method for uNK cell density estimation. JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 97(2), 183-185. doi:10.1016/j.jri.2012.12.002
PP.42 Investigation of Neonatal Encephalopathy: The Lost Placental ‘Black Box’
Gardner, D., Curley, A., Venkatesh, V., Turner, M. A., & Clarke, P. (2013). PP.42 Investigation of Neonatal Encephalopathy: The Lost Placental ‘Black Box’. Archives of Disease in Childhood - Fetal and Neonatal Edition, 98(Suppl 1), A93.3-A94. doi:10.1136/archdischild-2013-303966.322
PP.80 Identifying Research Uncertainties About Preterm Birth with Clinicians and Service Users
Uhm, S., Brady, D., Carroll, S., Chambers, B., Chivers, Z., Crowe, S., . . . Oliver, S. (2013). PP.80 Identifying Research Uncertainties About Preterm Birth with Clinicians and Service Users. Archives of Disease in Childhood - Fetal and Neonatal Edition, 98(Suppl 1), A103.1-A103. doi:10.1136/archdischild-2013-303966.355
What can we learn from parents about enhancing participation in pharmacovigilance?
Arnott, J., Hesselgreaves, H., Nunn, A. J., Peak, M., Pirmohamed, M., Smyth, R. L., . . . Young, B. (2013). What can we learn from parents about enhancing participation in pharmacovigilance?. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 75(4), 1109-1117. doi:10.1111/j.1365-2125.2012.04441.x
Wide intra- and inter-country variability in drug use and dosage in very-low-birth-weight newborns with severe infections
Pandolfini, C., Kaguelidou, F., Sequi, M., Jacqz-Aigrain, E., Choonara, I., Turner, M. A., . . . Bonati, M. (2013). Wide intra- and inter-country variability in drug use and dosage in very-low-birth-weight newborns with severe infections. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 69(4), 1031-1036. doi:10.1007/s00228-012-1415-2
GRP-001 1St ESNEE Excipient Monograph: Information Needed to Formulate, Prepare and Prescribe Medicines For Neonates Containing Propylene Glycol as an Excipient
Vaconsin, P., Storme, T., Masset, D., Nunn, A. J., Metsvaht, T., Carleer, J., . . . Rieutord, A. (2013). GRP-001 1St ESNEE Excipient Monograph: Information Needed to Formulate, Prepare and Prescribe Medicines For Neonates Containing Propylene Glycol as an Excipient. European Journal of Hospital Pharmacy, 20(Suppl 1), A1.1-A1. doi:10.1136/ejhpharm-2013-000276.001
Estimating the requirement for manipulation of medicines to provide accurate doses for children
Nunn, A., Richey, R., Shah, U., Barker, C., Craig, J., Peak, M., . . . Turner, M. (2013). Estimating the requirement for manipulation of medicines to provide accurate doses for children. EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 20(1), 3-7. doi:10.1136/ejhpharm-2012-000133
Randomized, Controlled Trial Evaluating a Baby Wash Product on Skin Barrier Function in Healthy, Term Neonates
Lavender, T., Bedwell, C., Roberts, S. A., Hart, A., Turner, M. A., Carter, L. -A., & Cork, M. J. (2013). Randomized, Controlled Trial Evaluating a Baby Wash Product on Skin Barrier Function in Healthy, Term Neonates. JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 42(2), 203-214. doi:10.1111/1552-6909.12015
2012
Adverse Drug Reactions Causing Admission to a Paediatric Hospital
Gallagher, R. M., Mason, J. R., Bird, K. A., Kirkham, J. J., Peak, M., Williamson, P. R., . . . Smyth, R. L. (2012). Adverse Drug Reactions Causing Admission to a Paediatric Hospital. PLOS ONE, 7(12). doi:10.1371/journal.pone.0050127
Enhancing Communication about Paediatric Medicines: Lessons from a Qualitative Study of Parents' Experiences of Their Child's Suspected Adverse Drug Reaction
Arnott, J., Hesselgreaves, H., Nunn, A. J., Peak, M., Pirmohamed, M., Smyth, R. L., . . . Young, B. (2012). Enhancing Communication about Paediatric Medicines: Lessons from a Qualitative Study of Parents' Experiences of Their Child's Suspected Adverse Drug Reaction. PLOS ONE, 7(10). doi:10.1371/journal.pone.0046022
1100 C-Reactive Protein Concentrations in Neonates with Hypoxic-Ischaemic Encephalopathy and Effect of Total Body Hypothermia
Sanka, S., Muniraman, H., Gardner, D., Pawaletz, A., Jennings, C., Vayalakkad, A., . . . Clarke, P. (2012). 1100 C-Reactive Protein Concentrations in Neonates with Hypoxic-Ischaemic Encephalopathy and Effect of Total Body Hypothermia. Archives of Disease in Childhood, 97(Suppl 2), A315. doi:10.1136/archdischild-2012-302724.1100
1109 Total Body Hypothermia and Circulating Biomarkers of Liver Function
Gardner, D., Sanka, S., Pawaletz, A., Muniraman, H., Jennings, C., Vayalakkad, A., . . . Turner, M. (2012). 1109 Total Body Hypothermia and Circulating Biomarkers of Liver Function. Archives of Disease in Childhood, 97(Suppl 2), A318. doi:10.1136/archdischild-2012-302724.1109
1325 Intra-Subject Variability on 3T MRI Imaging of Neonatal Hips
Hill, H., Murphy, A., Jacqz-Aigrain, E., Abernethy, L., & Turner, M. (2012). 1325 Intra-Subject Variability on 3T MRI Imaging of Neonatal Hips. Archives of Disease in Childhood, 97(Suppl 2), A377-A378. doi:10.1136/archdischild-2012-302724.1325
1342 Antibiotics for the Treatment and Prevention of Neonatal Early Onset Infection: Nice Guideline
Turner, M., Visintin, C., Mugglestone, M., & Murphy, M. (2012). 1342 Antibiotics for the Treatment and Prevention of Neonatal Early Onset Infection: Nice Guideline. Archives of Disease in Childhood, 97(Suppl 2), A382. doi:10.1136/archdischild-2012-302724.1342
1545 The Use of Drug Manipulation to Obtain Doses Required in Paediatric Practice: A Systematic Review
Richey, R., Craig, J., Shah, U., Ford, J., Barker, C., Peak, M., . . . Turner, M. (2012). 1545 The Use of Drug Manipulation to Obtain Doses Required in Paediatric Practice: A Systematic Review. Archives of Disease in Childhood, 97(Suppl 2), A437. doi:10.1136/archdischild-2012-302724.1545
1732 Risk Proportionate Classification by a National Competent Authority to Reduce Barriers for Clinical Trials
Hill, H., Jacques-Aigrain, E., & Turner, M. (2012). 1732 Risk Proportionate Classification by a National Competent Authority to Reduce Barriers for Clinical Trials. Archives of Disease in Childhood, 97(Suppl 2), A489. doi:10.1136/archdischild-2012-302724.1732
359 Intrasubject Variation in Estimates of Neonatal Intrahepatocellular Lipid using 1H Nmr Spectroscopy
Murphy, A., Adams, V., Hill, H., Morgan, C., Kemp, G., Abernethy, L., & Turner, M. (2012). 359 Intrasubject Variation in Estimates of Neonatal Intrahepatocellular Lipid using 1H Nmr Spectroscopy. Archives of Disease in Childhood, 97(Suppl 2), A105-A106. doi:10.1136/archdischild-2012-302724.0359
606 Diuretic use in Neonatal Chronic Lung Disease in England
Chahal, J., Jennings, D., & Turner, M. (2012). 606 Diuretic use in Neonatal Chronic Lung Disease in England. Archives of Disease in Childhood, 97(Suppl 2), A175-A176. doi:10.1136/archdischild-2012-302724.0606
Hospitalised neonates in Estonia commonly receive potentially harmful excipients
Lass, J., Naelapaa, K., Shah, U., Kaeaer, R., Varendi, H., Turner, M. A., & Lutsar, I. (2012). Hospitalised neonates in Estonia commonly receive potentially harmful excipients. BMC PEDIATRICS, 12. doi:10.1186/1471-2431-12-136
Mechanism-Based Urinary Biomarkers to Identify the Potential for Aminoglycoside-Induced Nephrotoxicity in Premature Neonates: A Proof-of-Concept Study
McWilliam, S. J., Antoine, D. J., Sabbisetti, V., Turner, M. A., Farragher, T., Bonventre, J. V., . . . Pirmohamed, M. (2012). Mechanism-Based Urinary Biomarkers to Identify the Potential for Aminoglycoside-Induced Nephrotoxicity in Premature Neonates: A Proof-of-Concept Study. PLOS ONE, 7(8). doi:10.1371/journal.pone.0043809
Antibiotic dosing in children in Europe: can we grade the evidence from pharmacokinetic/pharmacodynamic studies - and when is enough data enough?
Barker, C. I. S., Standing, J. F., Turner, M. A., McElnay, J. C., & Sharland, M. (2012). Antibiotic dosing in children in Europe: can we grade the evidence from pharmacokinetic/pharmacodynamic studies - and when is enough data enough?. CURRENT OPINION IN INFECTIOUS DISEASES, 25(3), 235-242. doi:10.1097/QCO.0b013e328353105c
Azithromycin, <i>Ureaplasma</i> and chronic lung disease of prematurity: a case study for neonatal drug development
Turner, M. A., Jacqz-Aigrain, E., & Kotecha, S. (2012). Azithromycin, <i>Ureaplasma</i> and chronic lung disease of prematurity: a case study for neonatal drug development. ARCHIVES OF DISEASE IN CHILDHOOD, 97(6), 573-577. doi:10.1136/adc.2010.195180
Standard 5: Selection, Measurement, and Reporting of Outcomes in Clinical Trials in Children
Sinha, I. P., Altman, D. G., Beresford, M. W., Boers, M., Clarke, M., Craig, J., . . . Smyth, R. L. (2012). Standard 5: Selection, Measurement, and Reporting of Outcomes in Clinical Trials in Children. PEDIATRICS, 129, S146-S152. doi:10.1542/peds.2012-0055H
Esnee project: strategy for the extensive review of the literature on excipient toxicities
Vaconsin, P., Storme, T., Salunke, S., Turner, M., Brion, F., & Rieutord, A. (2012). Esnee project: strategy for the extensive review of the literature on excipient toxicities. European Journal of Hospital Pharmacy, 19(2), 183.1-183. doi:10.1136/ejhpharm-2012-000074.259
Aberrant expression of metastasis-inducing proteins in ectopic and matched eutopic endometrium of women with endometriosis: implications for the pathogenesis of endometriosis
Hapangama, D. K., Raju, R. S., Valentijn, A. J., Barraclough, D., Hart, A., Turner, M. A., . . . Rudland, P. S. (2012). Aberrant expression of metastasis-inducing proteins in ectopic and matched eutopic endometrium of women with endometriosis: implications for the pathogenesis of endometriosis. HUMAN REPRODUCTION, 27(2), 394-407. doi:10.1093/humrep/der412
European Study for Neonatal Excipient Exposure (ESNEE)
Turner, M. A., & Storme, T. (2012). European Study for Neonatal Excipient Exposure (ESNEE). EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 19(2), 67. doi:10.1136/ejhpharm-2012-000065
The manipulation of drugs to obtain the required dose: systematic review
Richey, R. H., Craig, J. V., Shah, U. U., Ford, J. L., Barker, C. E., Peak, M., . . . Turner, M. A. (2012). The manipulation of drugs to obtain the required dose: systematic review. JOURNAL OF ADVANCED NURSING, 68(9), 2103-2112. doi:10.1111/j.1365-2648.2011.05916.x
2011
Development and Inter-Rater Reliability of the Liverpool Adverse Drug Reaction Causality Assessment Tool
Gallagher, R. M., Kirkham, J. J., Mason, J. R., Bird, K. A., Williamson, P. R., Nunn, A. J., . . . Pirmohamed, M. (2011). Development and Inter-Rater Reliability of the Liverpool Adverse Drug Reaction Causality Assessment Tool. PLOS ONE, 6(12). doi:10.1371/journal.pone.0028096
Endometrial cell counts in recurrent miscarriage: a comparison of counting methods
Drury, J. A., Nik, H., van Oppenraaij, R. H. F., Tang, A. -W., Turner, M. A., & Quenby, S. (2011). Endometrial cell counts in recurrent miscarriage: a comparison of counting methods. HISTOPATHOLOGY, 59(6), 1156-1162. doi:10.1111/j.1365-2559.2011.04046.x
Measurement of the urinary biomarker KIM-1 identifies the potential for aminoglycoside-induced nephrotoxicity in premature neonates
Antoine, D. J., McWilliam, S., Sabbisetti, V., Turner, M., Smyth, R., Pirmohamed, M., . . . Park, B. K. (2011). Measurement of the urinary biomarker KIM-1 identifies the potential for aminoglycoside-induced nephrotoxicity in premature neonates. In TOXICOLOGY Vol. 290 (pp. 107). doi:10.1016/j.tox.2011.09.015
Which inotrope and when in neonatal and paediatric intensive care?
Turner, M. A., & Baines, P. (2011). Which inotrope and when in neonatal and paediatric intensive care?. ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION, 96(6), 216-222. doi:10.1136/adc.2008.143925
AN INVESTIGATION OF THE MANIPULATION OF DRUGS TO GET THE REQUIRED DOSE IN NEONATAL PRACTICE
Richey, R. H., Shah, U. U., Barker, C. E., Donnell, C., Ford, J. L., Peak, M., . . . Turner, M. A. (2011). AN INVESTIGATION OF THE MANIPULATION OF DRUGS TO GET THE REQUIRED DOSE IN NEONATAL PRACTICE. In PEDIATRIC RESEARCH Vol. 70 (pp. 718). doi:10.1038/pr.2011.943
DIFFUSION TENSOR IMAGING OF THE INTERNAL CAPSULE AND CORPUS CALLOSUM OF PRETERM INFANTS BORN UNDER 28 WEEKS GESTATION
Atkinson, J. J., Parkes, L. M., Gamble, C., Ng, S. M., Turner, M., Weindling, A. M., . . . Sluming, V. (2011). DIFFUSION TENSOR IMAGING OF THE INTERNAL CAPSULE AND CORPUS CALLOSUM OF PRETERM INFANTS BORN UNDER 28 WEEKS GESTATION. PEDIATRIC RESEARCH, 70, 149. doi:10.1038/pr.2011.374
Neonatal drug development
Turner, M. A. (2011). Neonatal drug development. EARLY HUMAN DEVELOPMENT, 87(11), 763-768. doi:10.1016/j.earlhumdev.2011.08.014
URINARY KIM-1 AS A BIOMARKER OF AMINOGLYCOSIDE-INDUCED NEPHROTOXICITY IN PREMATURE NEONATES
McWilliam, S. J., Antoine, D. J., Turner, M., Sabbisetti, V., Bonventre, J. V., Park, B. K., . . . Pirmohamed, M. (2011). URINARY KIM-1 AS A BIOMARKER OF AMINOGLYCOSIDE-INDUCED NEPHROTOXICITY IN PREMATURE NEONATES. In PEDIATRIC RESEARCH Vol. 70 (pp. 107). doi:10.1038/pr.2011.332
Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units
Kadambari, S., Heath, P. T., Sharland, M., Lewis, S., Nichols, A., & Turner, M. A. (2011). Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 66(11), 2647-2650. doi:10.1093/jac/dkr351
Uncertainties in the measurement of blood glucose in paediatric intensive care: implications for clinical trials of tight glycaemic control
Hill, H., Baines, P., Barton, P., Newland, P., Terlouw, D., & Turner, M. (2011). Uncertainties in the measurement of blood glucose in paediatric intensive care: implications for clinical trials of tight glycaemic control. INTENSIVE CARE MEDICINE, 37(9), 1517-1524. doi:10.1007/s00134-011-2302-5
SCAMP: standardised, concentrated, additional macronutrients, parenteral nutrition in very preterm infants: a phase IV randomised, controlled exploratory study of macronutrient intake, growth and other aspects of neonatal care
Morgan, C., Herwitker, S., Badhawi, I., Hart, A., Tan, M., Mayes, K., . . . Turner, M. A. (2011). SCAMP: standardised, concentrated, additional macronutrients, parenteral nutrition in very preterm infants: a phase IV randomised, controlled exploratory study of macronutrient intake, growth and other aspects of neonatal care. BMC PEDIATRICS, 11. doi:10.1186/1471-2431-11-53
Cardiovascular support during neonatal intensive care
Paize, F., & Turner, M. A. (2011). Cardiovascular support during neonatal intensive care. Paediatrics and Child Health, 21(6), 241-246. doi:10.1016/j.paed.2011.02.005
Infant skin-cleansing product versus water: A pilot randomized, assessor-blinded controlled trial
Lavender, T., Bedwell, C., O'Brien, E., Cork, M. J., Turner, M., & Hart, A. (2011). Infant skin-cleansing product versus water: A pilot randomized, assessor-blinded controlled trial. BMC PEDIATRICS, 11. doi:10.1186/1471-2431-11-35
Adverse drug reactions causing admission to a paediatric hospital: a pilot study
Gallagher, R. M., Bird, K. A., Mason, J. R., Peak, M., Williamson, P. R., Nunn, A. J., . . . Smyth, R. L. (2011). Adverse drug reactions causing admission to a paediatric hospital: a pilot study. Journal of Clinical Pharmacy and Therapeutics, 36(2), 194-199. doi:10.1111/j.1365-2710.2010.01194.x
Adverse drug reactions causing admission to a paediatric hospital: a pilot study
Gallagher, R. M., Bird, K. A., Mason, J. R., Peak, M., Williamson, P. R., Nunn, A. J., . . . Smyth, R. L. (2011). Adverse drug reactions causing admission to a paediatric hospital: a pilot study. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 36(2), 194-199. doi:10.1111/j.1365-2710.2010.01194.x
An investigation of drug manipulation for dose accuracy in paediatric practice: the modric study
Richey, R. H., Donnell, C., Shah, U. U., Barker, C. E., Craig, J. V., Ford, J. L., . . . Nunn, A. J. (2011). An investigation of drug manipulation for dose accuracy in paediatric practice: the modric study. Archives of Disease in Childhood, 96(4), e1. doi:10.1136/adc.2011.211243.20
Plasma aminotransferase concentrations in preterm infants
Victor, S., Dickinson, H., & Turner, M. A. (2011). Plasma aminotransferase concentrations in preterm infants. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 96(2), F144-F145. doi:10.1136/adc.2008.152454
Ciprofloxacin Use in Neonates <i>A Systematic Review of the Literature</i>
Kaguelidou, F., Turner, M. A., Choonara, I., & Jacqz-Aigrain, E. (2011). Ciprofloxacin Use in Neonates <i>A Systematic Review of the Literature</i>. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 30(2), E29-E37. doi:10.1097/INF.0b013e3181fe353d
Use of dried blood spots to study excipient kinetics in neonates
Yakkundi, S., McElnay, J., Millership, J., Mulla, H., Pandya, H., Shah, U., . . . Turner, M. (2011). Use of dried blood spots to study excipient kinetics in neonates. BIOANALYSIS, 3(24), 2691-2693. doi:10.4155/BIO.11.277
2010
Safety of ciprofloxacin in neonates with sepsis
Bonati, M., Pandolfini, C., Kaguelidou, F., Jacqz-Aigrain, E., Turner, M., & Choonara, I. (2010). Safety of ciprofloxacin in neonates with sepsis. Adverse Drug Reaction Bulletin, &NA;(265), 1019-1022. doi:10.1097/fad.0b013e328342564b
512 Effect of Tidal Volume Information and Targeted Ventilator Training on the Incidence of Hypocarbia in the Early Neonatal Period
Misra, S., Morgan, C., Ganesan, K., & Turner, M. (2010). 512 Effect of Tidal Volume Information and Targeted Ventilator Training on the Incidence of Hypocarbia in the Early Neonatal Period. Pediatric Research, 68, 262. doi:10.1203/00006450-201011001-00512
Aberrant expression of regulators of cell-fate found in eutopic endometrium is found in matched ectopic endometrium among women and in a baboon model of endometriosis
Hapangama, D. K., Turner, M. A., Drury, J., Heathcote, L., Afshar, Y., Mavrogianis, P. A., & Fazleabas, A. T. (2010). Aberrant expression of regulators of cell-fate found in eutopic endometrium is found in matched ectopic endometrium among women and in a baboon model of endometriosis. HUMAN REPRODUCTION, 25(11), 2840-2850. doi:10.1093/humrep/deq248
FREE THYROXINE LEVELS IN THE INITIAL FOUR WEEKS OF LIFE IN EXTREME PRETERM INFANTS AFFECT BRAIN GROWTH
Ng, S. M., Turner, M. A., Didi, M., Gamble, C., Victor, S., Manning, D., . . . Weindling, A. M. (2010). FREE THYROXINE LEVELS IN THE INITIAL FOUR WEEKS OF LIFE IN EXTREME PRETERM INFANTS AFFECT BRAIN GROWTH. In PEDIATRIC RESEARCH Vol. 68 (pp. 206-207). doi:10.1203/00006450-201011001-00401
Compromised chorionic villous vascularization in idiopathic second trimester fetal loss
van Oppenraaij, R. H. F., Nik, H., Heathcote, L., McPartland, J. L., Turner, M. A., Quenby, S., . . . Exalto, N. (2010). Compromised chorionic villous vascularization in idiopathic second trimester fetal loss. EARLY HUMAN DEVELOPMENT, 86(8), 469-472. doi:10.1016/j.earlhumdev.2010.06.005
Correction
Correction (2010). Archives of Disease in Childhood - Fetal and Neonatal Edition, 95(4), F308. doi:10.1136/adc.2010.julycorr1
Points to Consider when Planning the Collection of Blood or Tissue Samples in Clinical Trials of Investigational Medicinal Products in Children, Infants and Neonates
Hawcutt, D. B., Rose, A. C., Fuerst-Recktenwald, S., Nunn, T., & Turner, M. A. (2010). Points to Consider when Planning the Collection of Blood or Tissue Samples in Clinical Trials of Investigational Medicinal Products in Children, Infants and Neonates. In GUIDE TO PAEDIATRIC DRUG DEVELOPMENT AND CLINICAL RESEARCH (pp. 97-110). Retrieved from https://www.webofscience.com/
Points to consider when planning the collection of blood or tissue samples in clinical trials of investigational medicinal products in children, infants and neonates
Hawcutt, D. B., Rose, A. C., Fuerst-Rectenwald, S., Nunn, A. J., & Turner, M. A. (2010). Points to consider when planning the collection of blood or tissue samples in clinical trials of investigational medicinal products in children, infants and neonates. In K. Rose, & J. van den Anker (Eds.), Guide to Paediatric Drug Development and Clinial Research (pp. 96-110). Basel: Karger.
2009
A qualitative study exploring women's and health professionals' views of newborn bathing practices
Lavender, T., Bedwell, C., Tsekiri-O'Brien, E., Hart, A., Turner, M., & Cork, M. (2009). A qualitative study exploring women's and health professionals' views of newborn bathing practices. Evidence Based Midwifery, 7(4), 112-121.
Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium
Tang, A. -W., Alfirevic, Z., Turner, M. A., Drury, J., & Quenby, S. (2009). Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium. Trials, 10(1). doi:10.1186/1745-6215-10-102
<i>The price of silence</i> 18 Liverpool consultants reply
Adams, E., Lewis-Jones, I., Alfirevic, Z., MacDonald, R., Dawood, F., Mallaiah, S., . . . Kirwan, J. (2009). <i>The price of silence</i> 18 Liverpool consultants reply. BMJ-BRITISH MEDICAL JOURNAL, 339. doi:10.1136/bmj.b4981
Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium
Tang, A. -W., Alfirevic, Z., Turner, M. A., Drury, J., & Quenby, S. (2009). Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium. TRIALS, 10. doi:10.1186/1745-6215-10-102
Prioritising neonatal medicines research: UK Medicines for Children Research Network scoping survey
Turner, M. A., Lewis, S., Hawcutt, D. B., & Field, D. (2009). Prioritising neonatal medicines research: UK Medicines for Children Research Network scoping survey. BMC PEDIATRICS, 9. doi:10.1186/1471-2431-9-50
Toxic additives in medication for preterm infants
Whittaker, A., Currie, A. E., Turner, M. A., Field, D. J., Mulla, H., & Pandya, H. C. (2009). Toxic additives in medication for preterm infants. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 94(4), F236-F240. doi:10.1136/adc.2008.146035
CSF cytokine levels in preterm infants may reflect systemic inflammation and are independent of gestation
Turner, M. A., Drury, J. A., Carlin, A., O'Neill, S., Pilling, D., Barnes, N., . . . Subhedar, N. V. (2009). CSF cytokine levels in preterm infants may reflect systemic inflammation and are independent of gestation. EARLY HUMAN DEVELOPMENT, 85(4), 259-262. doi:10.1016/j.earlhumdev.2008.10.011
IFPA Meeting 2008 Workshops Report
Lash, G. E., Ansari, T., Bischof, P., Burton, G. J., Chamley, L., Crocker, I., . . . Huppertz, B. (2009). IFPA Meeting 2008 Workshops Report. PLACENTA, 30, S4-S14. doi:10.1016/j.placenta.2008.11.014
Sustained replication in endometrium of women with endometriosis occurs without evoking a DNA damage response
Hapangama, D. K., Turner, M. A., Drury, J. A., Quenby, S., Hart, A., Maddick, M., . . . von Zglinicki, T. (2009). Sustained replication in endometrium of women with endometriosis occurs without evoking a DNA damage response. HUMAN REPRODUCTION, 24(3), 687-696. doi:10.1093/humrep/den416
Uterine natural killer cells and angiogenesis in recurrent reproductive failure
Quenby, S., Nik, H., Innes, B., Lash, G., Turner, M., Drury, J., & Bulmer, J. (2009). Uterine natural killer cells and angiogenesis in recurrent reproductive failure. HUMAN REPRODUCTION, 24(1), 45-54. doi:10.1093/humrep/den348
2008
Endometriosis is Associated With Aberrant Endometrial Expression of Telomerase and Increased Telomere Length
Hapangama, D. K., Turner, M. A., Drury, J. A., Quenby, S., Saretzki, G., Martin-Ruiz, C., & Von Zglinicki, T. (2008). Endometriosis is Associated With Aberrant Endometrial Expression of Telomerase and Increased Telomere Length. OBSTETRICAL & GYNECOLOGICAL SURVEY, 63(11), 711-713. doi:10.1097/01.ogx.0000334739.09119.28
Clinician observation of physiological trend monitoring to identify late-onset sepsis in preterm infants
Dewhurst, C. J., Cooke, R. W. I., & Turner, M. A. (2008). Clinician observation of physiological trend monitoring to identify late-onset sepsis in preterm infants. ACTA PAEDIATRICA, 97(9), 1187-1191. doi:10.1111/j.1651-2227.2008.00865.x
TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks gestation: Magnetic Resonance Imaging and Magnetic Resonance Angiography protocol
Ng, S. M., Turner, M. A., Gamble, C., Didi, M., Victor, S., Malamateniou, C., . . . Weindling, A. M. (2008). TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks gestation: Magnetic Resonance Imaging and Magnetic Resonance Angiography protocol. BMC PEDIATRICS, 8. doi:10.1186/1471-2431-8-26
TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks' gestation
Ng, S. M., Turner, M. A., Gamble, C., Didi, M., Victor, S., & Weindling, A. M. (2008). TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks' gestation. TRIALS, 9. doi:10.1186/1745-6215-9-17
Endometrial telomerase shows specific expression patterns in different types of reproductive failure
Hapangama, D. K., Turner, M. A., Drury, J. A., Martin-Ruiz, C., Von Zglinicki, T., Farquharson, R. G., & Quenby, S. (2008). Endometrial telomerase shows specific expression patterns in different types of reproductive failure. REPRODUCTIVE BIOMEDICINE ONLINE, 17(3), 416-424. doi:10.1016/S1472-6483(10)60227-1
Endometrial telomerase shows specific expression patterns in different types of reproductive failure.
Hapangama, D. K., Turner, M. A., Drury, J. A., Martin-Ruiz, C., Von Zglinicki, T., Farquharson, R. G., & Quenby, S. (2008). Endometrial telomerase shows specific expression patterns in different types of reproductive failure.. Reprod Biomed Online, 17(3), 416-424.
Endometriosis is associated with aberrant endometrial expression of telomerase and increased telomere length
Hapangama, D. K., Turner, M. A., Drury, J. A., Quenby, S., Saretzki, G., Martin-Ruiz, C., & Von Zglinicki, T. (2008). Endometriosis is associated with aberrant endometrial expression of telomerase and increased telomere length. HUMAN REPRODUCTION, 23(7), 1511-1519. doi:10.1093/humrep/den172
Points to consider when planning the collection of blood samples in clinical trials of investigational medicinal products.
Hawcutt, D. B., Rose, A. C., Nunn, T., & Turner, M. A. (2008). Points to consider when planning the collection of blood samples in clinical trials of investigational medicinal products.. Liverpool: Medicines for Children Research Network. Retrieved from http://ctuprod.liv.ac.uk/mcrnweb/images/mcrn_guide_for_blood_sampling_v1.0.pdf
TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks' gestation.
Ng, S. M., Turner, M. A., Gamble, C., Didi, M., Victor, S., & Weindling, A. M. (2008). TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks' gestation.. Trials, 26(9), 17.
TIPIT: a randomised controlled trial of thyroxine in preterm infants under 28 weeks gestation: magnetic resonance imaging and magnetic resonance angiography protocol.
Ng, S. M., Turner, M. A., Gamble, C., Didi, M., Victor, S., Malamateniou, C., . . . Weindling, A. M. (2008). TIPIT: a randomised controlled trial of thyroxine in preterm infants under 28 weeks gestation: magnetic resonance imaging and magnetic resonance angiography protocol.. BMC Pediatr., 8(26). Retrieved from http://www.biomedcentral.com/1471-2431/8/26
2007
Effect of maternal asthma on birthweight and neonatal outcome in a British inner-city population
Clark, J. M., Hulme, E., Devendrakumar, V., Turner, M. A., Baker, P. N., Sibley, C. P., & D'Souza, S. W. (2007). Effect of maternal asthma on birthweight and neonatal outcome in a British inner-city population. PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 21(2), 154-162. doi:10.1111/j.1365-3016.2007.00784.x
'Endometrial cell counts in recurrent miscarriage: A comparison of counting methods'
Drury, J., Nik, H., van Oppenraaij, R., Turner, M. A., & Quenby, S. (2007). 'Endometrial cell counts in recurrent miscarriage: A comparison of counting methods'. Placenta, 28(8-9), A36.
Isolated parenchymal lesions on cranial ultrasound in very preterm infants in the context of maternal infection
Turner, M. A., Vause, S., Howell, L., Wood, D., Herbert, E., Rimmer, S., . . . D'Souza, S. W. (2007). Isolated parenchymal lesions on cranial ultrasound in very preterm infants in the context of maternal infection. EARLY HUMAN DEVELOPMENT, 83(1), 63-68. doi:10.1016/j.earlhumdev.2006.05.007
Uterine NK cells and lymphatics in human endometrium
Quenby, S., van Oppenraaij, R. H. F., Nik, H., Drury, J., Innes, B., Turner, M., . . . Bulmer, J. N. (2007). Uterine NK cells and lymphatics in human endometrium. PLACENTA, 28(8-9), A27. Retrieved from https://www.webofscience.com/
2006
Implantation, trophoblast/decidual interactions and local inflammatory changes
Quenby, S., Vince, G., & Turner, M. (2006). Implantation, trophoblast/decidual interactions and local inflammatory changes. In Inflammation and Pregnancy (pp. 47-60). CRC Press. doi:10.1201/b14620-5
TASK channel expression in human placenta and cytotrophoblast cells
Bai, X. L., Lacey, H. A., Greenwood, S. L., Baker, P. N., Turner, M. A., Sibley, C. P., & Fyfe, G. K. (2006). TASK channel expression in human placenta and cytotrophoblast cells. JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 13(1), 30-39. doi:10.1016/j.jsgi.2005.10.005
The extent and variability of effects of culture conditions on the secretion of human chorionic gonadotrophin and interleukin-6 by human, term placental explants in culture
Turner, M. A., Roulstone, C. J., Desforges, M., Cretney, M., Champion, E., Lacey, H., & Greenwood, S. L. (2006). The extent and variability of effects of culture conditions on the secretion of human chorionic gonadotrophin and interleukin-6 by human, term placental explants in culture. PLACENTA, 27(1), 98-102. doi:10.1016/j.placenta.2004.12.004
The materno-fetal inflammatory response
Turner, M. A. (2006). The materno-fetal inflammatory response. In P. N. Baker, & C. P. Sibley (Eds.), The placenta and neurodisability (pp. x). London: MacKeith Press.
mplantation, trophoblast/decidual interactions and local inflammatory changes
Quenby, S., Vince, G. S., & Turner, M. A. (2006). mplantation, trophoblast/decidual interactions and local inflammatory changes. In Inflammation in Pregnancy (pp. xx). London: Taylor and Francis.
2005
Placental phenotypes of intrauterine growth
Sibley, C. P., Turner, M. A., Cetin, I., Ayuk, P., Boyd, C. A. R., D'Souza, S. W., . . . Powell, T. (2005). Placental phenotypes of intrauterine growth. PEDIATRIC RESEARCH, 58(5), 827-832. doi:10.1203/01.PDR.0000181381.82856.23
Human placental explants in culture: Approaches and assessments
Miller, R. K., Genbacev, O., Turner, M. A., Aplin, J. D., Caniggia, I., & Huppertz, B. (2005). Human placental explants in culture: Approaches and assessments. Placenta, 26(6), 439-448. doi:10.1016/j.placenta.2004.10.002
Effect of <i>Mycobacterium vaccae</i> on cytokine responses in children with atopic dermatitis
Hadley, E. A., Smillie, F. I., Turner, M. A., Custovic, A., Woodcock, A., & Arkwright, P. D. (2005). Effect of <i>Mycobacterium vaccae</i> on cytokine responses in children with atopic dermatitis. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 140(1), 101-108. doi:10.1111/j.1365-2249.2005.02743.x
Human placental explants in culture: Approaches and assessments
Miller, R. K., Genbacev, O., Turner, M. A., Aplin, J. D., Caniggia, I., & Huppertz, B. (2005). Human placental explants in culture: Approaches and assessments. PLACENTA, 26(6), 439-448. doi:10.1016/j.placenta.2004.10.002
2004
Gestational age and the C reactive protein response
Turner, M. A., Power, S., & Emmerson, A. J. B. (2004). Gestational age and the C reactive protein response. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 89(3), F272-F273. doi:10.1136/adc.2002.011288
The regulation of interleukin-6 secretion by prostanoids and members of the tumor necrosis factor superfamily in fresh villous fragments of term human placenta
Turner, M. A., Vause, S., & Greenwood, S. L. (2004). The regulation of interleukin-6 secretion by prostanoids and members of the tumor necrosis factor superfamily in fresh villous fragments of term human placenta. JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 11(3), 141-148. doi:10.1016/j.jsgi.2003.10.007
2002
Intravenous long-lines in children with cystic fibrosis: a multidisciplinary approach
Turner, M. A., Unsworth, V., & David, T. J. (2002). Intravenous long-lines in children with cystic fibrosis: a multidisciplinary approach. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 95, 11-21. Retrieved from https://www.webofscience.com/
Secretion of interleukin-1β and interleukin-6 by fragments of term human placental villi:: Signalling pathways and effects of tumour necrosis factor a and mode of delivery
Turner, M. A., Shaikh, S. A., & Greenwood, S. L. (2002). Secretion of interleukin-1β and interleukin-6 by fragments of term human placental villi:: Signalling pathways and effects of tumour necrosis factor a and mode of delivery. PLACENTA, 23(6), 467-474. doi:10.1053/plac.2002.0835
2001
The functional regeneration of syncytiotrophoblast in cultured explants of term placenta
Simán, C. M., Sibley, C. P., Jones, C. J. P., Turner, M. A., & Greenwood, S. L. (2001). The functional regeneration of syncytiotrophoblast in cultured explants of term placenta. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 280(4), R1116-R1122. doi:10.1152/ajpregu.2001.280.4.R1116
The functional regeneration of syncytiotrophoblast in cultured explants of term placenta.
Simán, C. M., Sibley, C. P., Jones, C. J., Turner, M. A., & Greenwood, S. L. (2001). The functional regeneration of syncytiotrophoblast in cultured explants of term placenta.. American journal of physiology. Regulatory, integrative and comparative physiology, 280(4), R1116-R1122. doi:10.1152/ajpregu.2001.280.4.r1116
2000
Oxalate and calcium excretion in cystic fibrosis
Turner, M. A., Goldwater, D., & David, T. J. (2000). Oxalate and calcium excretion in cystic fibrosis. ARCHIVES OF DISEASE IN CHILDHOOD, 83(3), 244-247. doi:10.1136/adc.83.3.244
1999
Anion efflux from cytotrophoblast cells derived from normal term human placenta is stimulated by hyposmotic challenge and extracellular A23187 but not by membrane-soluble cAMP
Turner, M. A., Sides, M. K., Sibley, C. P., & Greenwood, S. L. (1999). Anion efflux from cytotrophoblast cells derived from normal term human placenta is stimulated by hyposmotic challenge and extracellular A23187 but not by membrane-soluble cAMP. EXPERIMENTAL PHYSIOLOGY, 84(1), 27-40. doi:10.1111/j.1469-445X.1999.tb00069.x
1998
Regulation of CL− and K+ transport by the human placenta
Sibley, C. P., Greenwood, S. L., Glazier, J. D., Sides, M. K., & Turner, M. (1998). Regulation of CL− and K+ transport by the human placenta. Placenta, 19(7), A8. doi:10.1016/s0143-4004(98)91073-6
1997
Joint disorders in cystic fibrosis.
Turner, M. A., Baildam, E., Patel, L., & David, T. J. (1997). Joint disorders in cystic fibrosis.. Journal of the Royal Society of Medicine, 90 Suppl 31, 13-20. doi:10.1177/014107689709031s04
1991
HOLIDAYS AND ATOPIC ECZEMA
TURNER, M. A., DEVLIN, J., & DAVID, T. J. (1991). HOLIDAYS AND ATOPIC ECZEMA. ARCHIVES OF DISEASE IN CHILDHOOD, 66(2), 212-215. doi:10.1136/adc.66.2.212
Undated
2-Year Neurodevelopmental Outcomes in Children Who Received Sildenafil Therapy in Utero: The STRIDER RCT
Sharp, A., Cornforth, C., Jackson, R., Harrold, J., Turner, M. A., Kenny, L., . . . Group, S. T. R. I. D. E. R. (n.d.). 2-Year Neurodevelopmental Outcomes in Children Who Received Sildenafil Therapy in Utero: The STRIDER RCT.
A Randomised Trial Comparing Oral Misoprostol Alone with Oral Misoprostol Followed by Oxytocin in Women Induced for Hypertension of Pregnancy in India
Mundle, S., Lightly, K., Durocher, J., Bracken, H., Tadas, M., Parvekar, S., . . . Weeks, A. D. (n.d.). A Randomised Trial Comparing Oral Misoprostol Alone with Oral Misoprostol Followed by Oxytocin in Women Induced for Hypertension of Pregnancy in India.